# EDGAR Filing Document

**Accession Number:** 0000918965
**File Stem:** 0000918965-26-000013
**Filing Date:** 2026-2
**Character Count:** 200063
**Document Hash:** 33c7df00ce5ee82c49764fa677778a1e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000918965-26-000013.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0000918965-26-000013

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 80

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCANSOURCE, INC.
- **CENTRAL INDEX KEY:** 0000918965
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-COMPUTER & PERIPHERAL EQUIPMENT & SOFTWARE [5045]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 570965380
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26926
- **FILM NUMBER:** 26600664

**BUSINESS ADDRESS:**
- **STREET 1:** 6 LOGUE COURT
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29615
- **BUSINESS PHONE:** 800.944.2432

**MAIL ADDRESS:**
- **STREET 1:** 6 LOGUE COURT
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCANSOURCE INC
- **DATE OF NAME CHANGE:** 19940214

?xml version='1.0' encoding='ASCII'? scsc-20251231

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

 

**FORM 10-Q**

 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended December 31, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ____ to ____**

**Commission File Number: 000-26926**

 

![scansourcelogo4a291a06.jpg](scsc-20251231_g1.jpg)

---

| | | |
|:---|:---|:---|
| | **ScanSource, Inc.** | |
| (Exact name of registrant as specified in its charter) | (Exact name of registrant as specified in its charter) | (Exact name of registrant as specified in its charter) |
| **South Carolina** |  | **57-0965380** |
| (State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.) |
| **6 Logue Court** |  | **29615** |
| **Greenville, South Carolina** |  | (Zip Code) |
| (Address of principal executive offices) |  |  |

---

**(864) 288-2432** 

**(Registrant's telephone number, including area code)**

_______________________________________________

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of Each Exchange on Which Registered** |
| **Common Stock, no par value** | **SCSC** | **NASDAQ Global Select Market** |

---

**Securities registered pursuant to Section 12(g) of the Act:**

**None.**

_______________________________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

------

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Smaller reporting company | ☐ |
| Accelerated filer | ☐ | Emerging growth company | ☐ |
| Non-accelerated filer | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| **Class** | **Outstanding at February 2, 2026** |
| **Common Stock, no par value per share** | **21,480,385 shares** |

---

------

**SCANSOURCE, INC.**

**INDEX TO FORM 10-Q**

**December 31, 2025** 

---

| | | |
|:---|:---|:---|
| | | **Page #** |
| **<u>[PART I. FINANCIAL INFORMATION](#i33e5888db1e649d28b3e2a350904839f_13)</u>** | **<u>[PART I. FINANCIAL INFORMATION](#i33e5888db1e649d28b3e2a350904839f_13)</u>** | |
| &nbsp;&nbsp;Item 1. | <u>Financial Statements</u> | <u>[5](#i33e5888db1e649d28b3e2a350904839f_16)</u> |
|  | <u>[Condensed Consolidated Balance Sheets (unaudited) at](#i33e5888db1e649d28b3e2a350904839f_19)[Dec](#i33e5888db1e649d28b3e2a350904839f_19)[ember 3](#i33e5888db1e649d28b3e2a350904839f_19)[1](#i33e5888db1e649d28b3e2a350904839f_19)[, 2025 and June 30, 2025](#i33e5888db1e649d28b3e2a350904839f_19)</u> | <u>[5](#i33e5888db1e649d28b3e2a350904839f_19)</u> |
|  | <u>[Condensed Consolidated Income Statements (unaudited) for the Quarters](#i33e5888db1e649d28b3e2a350904839f_22)[and S](#i33e5888db1e649d28b3e2a350904839f_22)[ix Months](#i33e5888db1e649d28b3e2a350904839f_22)[ended](#i33e5888db1e649d28b3e2a350904839f_22)[Dec](#i33e5888db1e649d28b3e2a350904839f_22)[ember 3](#i33e5888db1e649d28b3e2a350904839f_22)[1](#i33e5888db1e649d28b3e2a350904839f_22)[, 2025 and 2024](#i33e5888db1e649d28b3e2a350904839f_22)</u> | <u>[6](#i33e5888db1e649d28b3e2a350904839f_22)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Income (unaudited) for the Quarters](#i33e5888db1e649d28b3e2a350904839f_25)[and Six Months](#i33e5888db1e649d28b3e2a350904839f_25)[ended](#i33e5888db1e649d28b3e2a350904839f_25)[Dec](#i33e5888db1e649d28b3e2a350904839f_25)[ember 3](#i33e5888db1e649d28b3e2a350904839f_25)[1](#i33e5888db1e649d28b3e2a350904839f_25)[, 2025 and 2024](#i33e5888db1e649d28b3e2a350904839f_25)</u> | <u>[7](#i33e5888db1e649d28b3e2a350904839f_25)</u> |
|  | <u>[Condensed Consolidated Statements of Shareholders' Equity (unaudited) for the Quarters](#i33e5888db1e649d28b3e2a350904839f_28)[and Six Mo](#i33e5888db1e649d28b3e2a350904839f_28)[nths](#i33e5888db1e649d28b3e2a350904839f_28)[ended](#i33e5888db1e649d28b3e2a350904839f_28)[Dec](#i33e5888db1e649d28b3e2a350904839f_28)[ember 3](#i33e5888db1e649d28b3e2a350904839f_28)[1](#i33e5888db1e649d28b3e2a350904839f_28)[, 2025 and 2024](#i33e5888db1e649d28b3e2a350904839f_28)</u> | <u>[8](#i33e5888db1e649d28b3e2a350904839f_28)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows (unaudited) for the](#i33e5888db1e649d28b3e2a350904839f_31)[Six](#i33e5888db1e649d28b3e2a350904839f_31)[Months Ended](#i33e5888db1e649d28b3e2a350904839f_31)[Dec](#i33e5888db1e649d28b3e2a350904839f_31)[ember 3](#i33e5888db1e649d28b3e2a350904839f_31)[1](#i33e5888db1e649d28b3e2a350904839f_31)[, 2025 and 2024](#i33e5888db1e649d28b3e2a350904839f_31)</u> | <u>[10](#i33e5888db1e649d28b3e2a350904839f_31)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#i33e5888db1e649d28b3e2a350904839f_34)</u> | <u>[11](#i33e5888db1e649d28b3e2a350904839f_34)</u> |
| &nbsp;&nbsp;Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i33e5888db1e649d28b3e2a350904839f_91)</u> | <u>[29](#i33e5888db1e649d28b3e2a350904839f_91)</u> |
| &nbsp;&nbsp;Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i33e5888db1e649d28b3e2a350904839f_169)</u> | <u>[48](#i33e5888db1e649d28b3e2a350904839f_169)</u> |
| &nbsp;&nbsp;Item 4. | <u>[Controls and Procedures](#i33e5888db1e649d28b3e2a350904839f_172)</u> | <u>[49](#i33e5888db1e649d28b3e2a350904839f_172)</u> |
| **<u>[PART II. OTHER INFORMATION](#i33e5888db1e649d28b3e2a350904839f_175)</u>** | **<u>[PART II. OTHER INFORMATION](#i33e5888db1e649d28b3e2a350904839f_175)</u>** |  |
| &nbsp;&nbsp;Item 1. | <u>[Legal Proceedings](#i33e5888db1e649d28b3e2a350904839f_178)</u> | <u>[50](#i33e5888db1e649d28b3e2a350904839f_178)</u> |
| &nbsp;&nbsp;Item 1A. | <u>[Risk Factors](#i33e5888db1e649d28b3e2a350904839f_181)</u> | <u>[50](#i33e5888db1e649d28b3e2a350904839f_181)</u> |
| &nbsp;&nbsp;Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i33e5888db1e649d28b3e2a350904839f_184)</u> | <u>[50](#i33e5888db1e649d28b3e2a350904839f_184)</u> |
| &nbsp;&nbsp;Item 5. | <u>[Other Information](#i33e5888db1e649d28b3e2a350904839f_187)</u> | <u>[51](#i33e5888db1e649d28b3e2a350904839f_187)</u> |
| &nbsp;&nbsp;Item 6. | <u>[Exhibits](#i33e5888db1e649d28b3e2a350904839f_193)</u> | <u>[52](#i33e5888db1e649d28b3e2a350904839f_193)</u> |
| **<u>[SIGNATURES](#i33e5888db1e649d28b3e2a350904839f_196)</u>** | **<u>[SIGNATURES](#i33e5888db1e649d28b3e2a350904839f_196)</u>** | <u>[53](#i33e5888db1e649d28b3e2a350904839f_196)</u> |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**FORWARD-LOOKING STATEMENTS**

Forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") included in the "Risk Factors," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Quantitative and Qualitative Disclosures About Market Risk" sections and elsewhere herein. Words such as "expects," "anticipates," "believes," "intends," "plans," "hopes," "forecasts," "seeks," "estimates," "goals," "projects," "strategy," "future," "likely," "may," "should," "will," and variations of such words and similar expressions generally identify such forward-looking statements. Any forward-looking statement made by us in this Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. Except as may be required by law, we expressly disclaim any obligation to update these forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control. You should not place undue reliance on forward-looking statements as actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors including, but not limited to the following factors, which are neither presented in order of importance nor weighted: macroeconomic conditions, including potential prolonged economic weakness, inflation and supply chain challenges, tariffs and changes in trade policy, the failure to manage and implement the Company's growth strategy, the Company's ability to realize the synergies or other benefits from acquisitions, credit risks involving the Company's larger channel sales partners and suppliers, changes in interest and exchange rates and regulatory regimes impacting the Company's international operations, including new or increased tariffs, risk to the Company's business from a cyber attack, a failure of the Company's IT systems, failure to hire and retain quality employees, loss of the Company's major channel sales partners, relationships with the Company's key suppliers and channel sales partners or a termination or a significant modification of the terms under which it operates with such suppliers and channel sales partners, changes in the Company's operating strategy and other factors set forth in "Risk Factors" contained in our Annual Report on Form 10-K for the year ended June 30, 2025.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**PART I. FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Financial Statements** |

---

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

**(In thousands, except share information)** 

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **June 30, 2025** |
| <u>Assets</u> |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**83466** | $126157 |
| &nbsp;&nbsp;Accounts receivable, less allowance of $31,534 at December 31, 2025<br>and $27,821 at June 30, 2025 | **605411** | 635521 |
| &nbsp;&nbsp;&nbsp;Inventories | **490259** | 483815 |
| &nbsp;&nbsp;&nbsp;Prepaid income tax expense | **11208** | 2821 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **112727** | 122138 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **1303071** | 1370452 |
| Property and equipment, net | **32158** | 31169 |
| Goodwill | **244178** | 230820 |
| Identifiable intangible assets, net | **72423** | 62909 |
| Deferred income taxes | **14172** | 18769 |
| Other non-current assets | **75669** | 71487 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**1741671** | $1785606 |
| <u>Liabilities and Shareholders' Equity</u> |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $**576662** | $598595 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | **67982** | 71263 |
| &nbsp;&nbsp;&nbsp;Current portion of contingent consideration | **16447** | 1318 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | **274** | 3927 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | **2866** | 7861 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **664231** | 682964 |
| Long-term debt, net of current portion | **99797** | 128288 |
| Long-term portion of contingent consideration | **12153** | 17782 |
| Other long-term liabilities | **54604** | 50163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | **830785** | 879197 |
| Commitments and contingencies |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;Preferred stock, no par value; 3,000,000 shares authorized, none issued | **—** |  |
| &nbsp;&nbsp;Common stock, no par value; 45,000,000 shares authorized, 21,645,381 and 22,217,421 shares issued and outstanding at December 31, 2025 and June 30, 2025, respectively | **—** |  |
| &nbsp;&nbsp;&nbsp;Retained earnings | **1027300** | 1020833 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(116414)** | (114424) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | **910886** | 906409 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $**1741671** | $1785606 |
| June 30, 2025 amounts are derived from audited consolidated financial statements. | June 30, 2025 amounts are derived from audited consolidated financial statements. | June 30, 2025 amounts are derived from audited consolidated financial statements. |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED INCOME STATEMENTS (UNAUDITED)**

**(In thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net sales | $**766512** | $747497 | $**1506162** | $1523077 |
| Cost of goods sold | **663602** | 645774 | **1295779** | 1319735 |
| &nbsp;&nbsp;&nbsp;Gross profit | **102910** | 101723 | **210383** | 203342 |
| Selling, general and administrative expenses | **78114** | 73920 | **153388** | 145626 |
| Depreciation expense | **1434** | 2902 | **3011** | 5759 |
| Intangible amortization expense | **4285** | 5001 | **8689** | 9359 |
| Restructuring expense | **—** | 313 | **—** | 5381 |
| Change in fair value of contingent consideration | **1209** | 1143 | **1523** | 1143 |
| &nbsp;&nbsp;&nbsp;Operating income | **17868** | 18444 | **43772** | 36074 |
| Interest expense | **1946** | 1970 | **3859** | 4078 |
| Interest income | **(3363)** | (2693) | **(6543)** | (5352) |
| Other (income) expense, net | **(136)** | (543) | **37** | (5325) |
| &nbsp;&nbsp;&nbsp;Income before income taxes | **19421** | 19710 | **46419** | 42673 |
| Provision for income taxes | **2928** | 2657 | **10047** | 8645 |
| Net income | $**16493** | $17053 | $**36372** | $34028 |
| Per share data: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, basic | $**0.75** | $0.72 | $**1.66** | $1.42 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding, basic | **21865** | 23806 | **21942** | 23976 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, diluted | $**0.75** | $0.70 | $**1.63** | $1.39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding, diluted | **22110** | 24217 | **22248** | 24450 |

---

See accompanying notes to these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)**

**(In thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net income | $**16493** | $17053 | $**36372** | $34028 |
| Unrealized (loss) gain on hedged transaction, net of tax | **(161)** | 266 | **(390)** | (784) |
| Foreign currency translation adjustment | **(5565)** | (18744) | **(1600)** | (14635) |
| &nbsp;&nbsp;Comprehensive income | $**10767** | $(1425) | $**34382** | $18609 |

---

See accompanying notes to these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

**(In thousands, except share information)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common<br>Stock<br>(Shares)** | **Common<br>Stock<br>(Amount)** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total** |
| Balance at June 30, 2025 | 22217421 | $— | $1020833 | $(114424) | $906409 |
| &nbsp;&nbsp;&nbsp;Net income |  |  | 19878 |  | 19878 |
| &nbsp;&nbsp;&nbsp;Unrealized loss on hedged transaction, net of tax |  |  |  | (230) | (230) |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment |  |  |  | 3966 | 3966 |
| &nbsp;&nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 339444 | 2218 |  |  | 2218 |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | (489737) | (5094) | (15991) |  | (21085) |
| &nbsp;&nbsp;&nbsp;Share-based compensation |  | 2876 |  |  | 2876 |
| Balance at September 30, 2025 | 22067128 | $— | $1024720 | $(110688) | $914032 |
| &nbsp;&nbsp;&nbsp;Net income | **—** | $**—** | $**16493** | $**—** | $**16493** |
| &nbsp;&nbsp;&nbsp;Unrealized loss on hedged transaction, net of tax | **—** | **—** | **—** | **(161)** | **(161)** |
| &nbsp;&nbsp;Foreign currency translation adjustment | **—** | **—** | **—** | **(5565)** | **(5565)** |
| &nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | **2025** | **2** | **—** | **—** | **2** |
| &nbsp;&nbsp;Common stock repurchased, including excise tax | **(423772)** | **(3664)** | **(13913)** | **—** | **(17577)** |
| &nbsp;&nbsp;Share-based compensation | **—** | **3662** | **—** | **—** | **3662** |
| Balance at December 31, 2025 | **21645381** | $**—** | $**1027300** | $**(116414)** | $**910886** |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

**(In thousands, except share information)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common<br>Stock<br>(Shares)** | **Common<br>Stock<br>(Amount)** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total** |
| Balance at June 30, 2024 | 24243848 | $26370 | $1013738 | $(115853) | $924255 |
| &nbsp;&nbsp;&nbsp;Net income |  |  | 16974 |  | 16974 |
| &nbsp;&nbsp;&nbsp;Unrealized loss on hedged transaction, net of tax |  |  |  | (1050) | (1050) |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment |  |  |  | 4109 | 4109 |
| &nbsp;&nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 349277 | 2177 |  |  | 2177 |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | (588018) | (28043) |  |  | (28043) |
| &nbsp;&nbsp;&nbsp;Share-based compensation |  | 2471 |  |  | 2471 |
| Balance at September 30, 2024 | 24005107 | $2975 | $1030712 | $(112794) | $920893 |
| &nbsp;&nbsp;&nbsp;Net income |  | $— | $17053 | $— | $17053 |
| &nbsp;&nbsp;&nbsp;Unrealized gain on hedged transaction, net of tax |  |  |  | 266 | 266 |
| &nbsp;&nbsp;Foreign currency translation adjustment |  |  |  | (18744) | (18744) |
| &nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 102489 | 2508 |  |  | 2508 |
| &nbsp;&nbsp;Common stock repurchased, including excise tax | (495053) | (8504) | (15831) |  | (24335) |
| &nbsp;&nbsp;Share-based compensation |  | 3021 |  |  | 3021 |
| Balance at December 31, 2024 | 23612543 | $— | $1031934 | $(131272) | $900662 |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

 **SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

**(In thousands)**

---

| | | |
|:---|:---|:---|
| | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** |
| | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $**36372** | $34028 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **12138** | 15603 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issue costs | **434** | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for doubtful accounts | **5580** | 5925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **6536** | 5492 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **32** | 2306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **1523** | 1143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease interest | **28** | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **24077** | 21110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(6618)** | 16316 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | **945** | (380) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | **(3861)** | 3145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **(21383)** | (64915) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | **1872** | (1834) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **(3623)** | 462 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | **54052** | 38642 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | **(4370)** | (4348) |
| &nbsp;&nbsp;&nbsp;Cash paid for business acquisitions, net of cash acquired | **(18358)** | (56673) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of business, net of cash transferred | **—** | 2569 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | **(22728)** | (58452) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Borrowings on revolving credit | **141738** | 26587 |
| &nbsp;&nbsp;&nbsp;Repayments on revolving credit | **(141738)** | (26636) |
| &nbsp;&nbsp;&nbsp;Borrowings on long-term debt | **100000** |  |
| &nbsp;&nbsp;&nbsp;Repayments on long-term debt | **(133486)** | (4107) |
| &nbsp;&nbsp;&nbsp;Repayments on finance lease obligation | **(523)** | (547) |
| &nbsp;&nbsp;&nbsp;Debt issuance costs | **(1417)** |  |
| &nbsp;&nbsp;&nbsp;Contingent consideration payments | **(1375)** |  |
| &nbsp;&nbsp;&nbsp;Exercise of stock options | **4854** | 9489 |
| &nbsp;&nbsp;&nbsp;Taxes paid on settlement of equity awards | **(2634)** | (4805) |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | **(38687)** | (52342) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | **(73268)** | (52361) |
| Effect of exchange rate changes on cash and cash equivalents | **(747)** | (2769) |
| Decrease in cash and cash equivalents | **(42691)** | (74940) |
| Cash and cash equivalents at beginning of period | **126157** | 185460 |
| Cash and cash equivalents at end of period | $**83466** | $110520 |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**(1) Business and Summary of Significant Accounting Policies**

*Business Description*

ScanSource, Inc. (together with its subsidiaries referred to as "the Company" or "ScanSource") is a leading technology distributor uniquely positioned to address complex, converging technologies and to accelerate growth for channel sales partners across hardware, software as a service ("SaaS"), connectivity and cloud services. ScanSource uses multiple sales models to offer technology solutions from leading suppliers of specialty technologies, connectivity and cloud services. The Company operates primarily in the United States and Brazil. The Company's two operating segments, Specialty Technology Solutions and Intelisys & Advisory, represent the different sales models the Company uses in executing its technology distribution growth strategy.

*Basis of Presentation*

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared by the Company's management in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and applicable rules and regulations of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. The unaudited condensed consolidated financial statements included herein contain all adjustments (consisting of normal recurring and non-recurring adjustments) that are, in the opinion of management, necessary to present fairly the financial position at December 31, 2025 and June 30, 2025, the results of operations for the quarters and six months ended December 31, 2025 and 2024, the condensed consolidated statements of comprehensive income for the quarters and six months ended December 31, 2025 and 2024, the condensed consolidated statements of shareholders' equity for the quarters and six months ended December 31, 2025 and 2024 and the condensed consolidated statements of cash flows for the six months ended December 31, 2025 and 2024. The results of operations for the quarters and six months ended December 31, 2025 are not necessarily indicative of the results to be expected for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

*Summary of Significant Accounting Policies*

There have been no material changes to the Company's significant accounting policies for the six months ended December 31, 2025 from the policies described in the notes to the Company's consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2025. For a discussion of the Company's significant accounting policies, please see the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

*Cash and Cash Equivalents*

The Company considers all highly-liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. The Company maintains zero-balance disbursement accounts at various financial institutions at which the Company does not maintain significant depository relationships. Due to the terms of the agreements governing these accounts, the Company generally does not have the right to offset outstanding checks written from these accounts against cash on hand, and the respective institutions are not legally obligated to honor the checks until sufficient funds are transferred to fund the checks. As a result, checks released but not yet cleared from these accounts were approximately $0.2 million and $0.1 million and are included in accounts payable on the condensed consolidated balance sheets at December 31, 2025 and June 30, 2025, respectively.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

*Long-lived Assets*

The Company presents depreciation expense and intangible amortization expense on the condensed consolidated income statements. The Company's depreciation expense related to selling, general and administrative costs totaled $1.4 million and $3.0 million for the quarter and six months ended December 31, 2025, respectively, and $2.9 million and $5.8 million for the quarter and six months ended December 31, 2024, respectively. Depreciation expense reported as part of cost of goods sold on the condensed consolidated income statements totaled $0.2 million and $0.4 million for the quarter and six months ended December 31, 2025, respectively, and $0.2 million and $0.5 million for the quarter and six months ended December 31, 2024, respectively. The Company's intangible amortization expense reported on the condensed consolidated income statements relates to selling, general and administrative costs, not the cost of selling goods. Intangible amortization expense totaled $4.3 million and $8.7 million for the quarter and six months ended December 31, 2025, respectively, and $5.0 million and $9.4 million for the quarter and six months ended December 31, 2024, respectively.

*Recent Accounting Pronouncements*

In December 2023, the FASB issued ASU No. 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024 and is applicable to the Company's fiscal year beginning July 1, 2025, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

In November 2024, the FASB issued ASU 2024-03 "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." This ASU requires public entities to disclose specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. This ASU is applicable to the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2028, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU 2025-06 "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." This standard is intended to improve the operability and application of guidance related to capitalized software development costs. The ASU is effective for annual reporting periods beginning after December 15, 2027, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

The Company has reviewed other newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated financial statements as a result of future adoption.

**(2) Trade Accounts and Notes Receivable, Net**

The Company maintains an allowance for doubtful accounts receivable for estimated future expected credit losses resulting from channel sales partners' failure to make payments on accounts receivable due to the Company. The Company has notes receivable with certain channel sales partners, which are included in "Accounts receivable, less allowance" in the Condensed Consolidated Balance Sheets.

Management determines the estimate of the allowance for doubtful accounts receivable by considering a number of factors, including: (i) historical experience, (ii) aging of the accounts receivable, (iii) specific information obtained by the Company on the financial condition and the current creditworthiness of its channel sales partners, (iv) the current economic and country-specific environment and (v) reasonable and supportable forecasts about collectability. Expected credit losses are estimated on a pool basis when similar risk characteristics exist using an age-based reserve model. Receivables that do not share risk characteristics are evaluated on an individual basis. Estimates of expected credit losses on trade receivables over the contractual life are recorded at inception and adjusted over the contractual life.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The changes in the allowance for doubtful accounts for the six months ended December 31, 2025 are set forth in the table below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **Amounts Charged to Expense** | **Write-offs** | **Other** <sup>(1)</sup> | **December 31, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Trade accounts and current notes receivable allowance | $**27821** | $**5580** | $**(1461)** | $**(406)** | $**31534** |

---

<sup>(1)</sup> "Other" amounts include recoveries and the effect of foreign currency fluctuations for the six months ended December 31, 2025.

**(3) Revenue Recognition**

The Company provides technology solutions and services from the world's leading suppliers of mobility and barcode, POS, payment terminals, physical security, networking communications, connectivity and cloud services. This includes hardware, related accessories and device configuration as well as software licenses, professional services and hardware support programs. Substantially all of the Company's revenues are derived from products sold at a point-in-time.

In determining the appropriate amount of revenue to recognize, the Company applies the following five-step model in accordance with ASC 606: (i) identify contracts with customers; (ii) identify performance obligations in the contracts; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations per the contracts; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company recognizes revenue as control of products and services are transferred to customers, which is generally at the point of shipment. The Company delivers products to customers in several ways, including: (i) shipment from a Company warehouse, (ii) drop-shipment directly from the supplier, or (iii) electronic delivery for non-physical products.

*Principal versus Agent Considerations*

The Company is the principal for sales of all hardware and certain software and services. The Company considers itself the principal in those transactions where it has control of the product or service before it is transferred to the customer. The Company recognizes the principal-associated revenue and cost of goods sold on a gross basis.

The Company is the agent for third-party service contracts, including product warranties and supplier-hosted software. These service contracts are sold separately from the products, and the Company often serves as the agent for the contract on behalf of the original equipment manufacturer. The Company's responsibility is to arrange for the provision of the specified service by the original equipment manufacturer, and the Company does not control the specified service before it is transferred to the customer. Because the Company acts as an agent, revenue is recognized net of cost at the time of sale. The Intelisys business operates under an agency model.

*Variable Considerations*

For certain transactions, products are sold with a right of return and may also provide other rebates or incentives, which are accounted for as variable consideration. The Company estimates a returns allowance based on historical experience and reduces revenue accordingly. The Company estimates the amount of variable consideration for rebates and incentives by using the expected value to be given to the customer and reduces the revenue by those estimated amounts. These estimates are reviewed and updated as necessary at the end of each reporting period.

*Contract Balances*

The Company records contract assets for services performed in advance of payments being received from channel sales partners. The Company records contract liabilities for payments received from channel sales partners in advance of services performed. These assets and liabilities are the result of the sales of the Company's self-branded warranty programs and other transactions where control has not yet passed to the customer. These amounts are immaterial to the consolidated financial statements for the periods presented.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

*Disaggregation of Revenue*

The following tables represent the Company's disaggregation of revenue:

---

| | | | |
|:---|:---|:---|:---|
| | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | | ***(in thousands)*** | |
| Revenue by product/service |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $**723387** | $**1102** | $**724489** |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | **18153** | **23870** | **42023** |
|  | $**741540** | $**24972** | $**766512** |
|  | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** |
|  | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
|  |  | ***(in thousands)*** |  |
| Revenue by product/service: |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $**1425018** | $**2455** | $**1427473** |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | **31969** | **46720** | **78689** |
|  | $**1456987** | $**49175** | $**1506162** |
| (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | | ***(in thousands)*** | |
| Revenue by product/service |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $710858 | $377 | $711235 |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | 12419 | 23843 | 36262 |
|  | $723277 | $24220 | $747497 |
|  | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** |
|  | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
|  |  | ***(in thousands)*** |  |
| Revenue by product/service: |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $1451592 | $1210 | $1452802 |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | 23984 | 46291 | 70275 |
|  | $1475576 | $47501 | $1523077 |
| (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**(4) Earnings Per Share**

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding. Diluted earnings per share are computed by dividing net income by the weighted-average number of common and potential common shares outstanding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
|  | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $**16493** | $17053 | $**36372** | $34028 |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;Weighted-average shares, basic | **21865** | 23806 | **21942** | 23976 |
| &nbsp;&nbsp;Dilutive effect of share-based payments | **245** | 411 | **306** | 474 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares, diluted | **22110** | 24217 | **22248** | 24450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, basic | $**0.75** | $0.72 | $**1.66** | $1.42 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, diluted | $**0.75** | $0.70 | $**1.63** | $1.39 |

---

For the quarter and six months ended December 31, 2025, weighted-average shares outstanding excluded from the computation of diluted earnings per share because their effect would be anti-dilutive were 320,233 and 435,768, respectively. For the quarter and six months ended December 31, 2024, weighted-average shares outstanding excluded from the computation of diluted earnings per share because their effect would be anti-dilutive were 197,803 and 210,206, respectively.

**(5) Accumulated Other Comprehensive Loss**

The components of accumulated other comprehensive loss, net of tax are as follows:

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| Foreign currency translation adjustment | $**(116534)** | $(114934) |
| Unrealized gain on hedged transaction, net of tax | **120** | 510 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | $**(116414)** | $(114424) |

---

The tax effect of amounts in comprehensive loss reflect a tax (benefit) expense as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | **Six months ended December 31,** | **Six months ended December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Tax (benefit) expense | $**(89)** | $157 | $**(134)** | $(206) |

---

**(6) Goodwill and Other Identifiable Intangible Assets**

The changes in the carrying amount of goodwill for the six months ended December 31, 2025, by reporting segment, are set forth in the table below.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Balance at June 30, 2025 | $159779 | $71041 | $230820 |
| &nbsp;&nbsp;Additions | 13465 |  | 13465 |
| &nbsp;&nbsp;Foreign currency translation adjustment | (101) | (6) | (107) |
| Balance at December 31, 2025 | $**173143** | $**71035** | $**244178** |

---

The following table shows changes in the amount recognized for net identifiable intangible assets for the six months ended December 31, 2025.

---

| | |
|:---|:---|
| | **Net Identifiable Intangible Assets** |
| | ***(in thousands)*** |
| Balance at June 30, 2025 | $62909 |
| &nbsp;&nbsp;Additions | 18200 |
| &nbsp;&nbsp;Amortization expense | (8689) |
| &nbsp;&nbsp;Foreign currency translation adjustment | 3 |
| Balance at December 31, 2025 | $**72423** |

---

Additions to goodwill and intangible assets are due to the recent DataXoom acquisition. Intangible assets include trade name, developed technology and customer relationships.

**(7) Short-Term Borrowings and Long-Term Debt**

The following table presents the Company's debt at December 31, 2025 and June 30, 2025.

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| Current portion of long-term debt | $**2866** | $7861 |
| Mississippi revenue bond, net of current portion | **2297** | 2663 |
| Senior secured term loan facility, net of current portion | **97500** | 125625 |
| &nbsp;&nbsp;Total debt | $**102663** | $136149 |

---

*Credit Facility*

On December 18, 2025, the Company entered into a credit agreement (the "New Credit Agreement") with PNC Bank, National Association, as administrative agent ("PNC"), and the other lenders party thereto (the "Lenders"), providing for (i) a five-year, $400 million multicurrency senior secured revolving credit facility and (ii) a five-year $100 million senior secured term loan facility (the "New Credit Facilities"). In addition, pursuant to an "accordion feature," the Company may increase its borrowings by up to the greater of $250 million or 150% of the Company's EBITDA calculated on a Pro Forma Basis (each as defined in the New Credit Agreement), subject to obtaining additional credit commitments from the Lenders participating in the increase. The New Credit Agreement allows for issuance of up to $50 million for letters of credit. Borrowings under the New Credit Agreement are secured by substantially all of the assets of the Company and its domestic subsidiaries. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. The Company incurred debt issuance costs of $1.4 million in connection with the New Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.

Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at the Company's option, (i) the Term Secured Overnight Financing Rate ("SOFR") or daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's ratio of (A) total consolidated debt less its unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the "leverage ratio"); or (ii) the base rate plus an additional margin

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

ranging from 0% to 0.75%, depending upon the Company's leverage ratio. All swingline loans denominated in U.S. dollars bear interest based upon the daily simple SOFR, floating daily, plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's leverage ratio, or such other rate as the Company and the applicable swingline lender may agree. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the New Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon the Company's leverage ratio. A commitment fee is payable on the unused amount of commitments under the revolving credit facility. The commitment fee ranges from 0.15% to 0.30%, depending on the Company's leverage ratio.

In connection with entering into the New Credit Agreement, on December 18, 2025, the Company terminated and repaid all indebtedness and other obligations outstanding under its Third Amended and Restated Credit Agreement (the "Prior Credit Agreement") with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto, which provided for (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility.

During the quarter and six months ended December 31, 2025, all of the Company's borrowings under New Credit Agreement and Prior Credit Agreement were U.S. dollar loans. The spread in effect as of December 31, 2025 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at December 31, 2025 was 0.15%. The effective interest rates for the term loan were 4.72% and 5.43% as of December 31, 2025 and June 30, 2025, respectively. The New Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, the Company's leverage ratio must be less than or equal to 3.50 to 1.00. In addition, the Company's Interest Coverage Ratio (as such term is defined in the New Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. The Company was in compliance with all covenants under the New Credit Agreement at December 31, 2025.

The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, was $1.7 million and $0.3 million during the six month periods ended December 31, 2025 and 2024, respectively. There was $400.0 million and $350.0 million available for additional borrowings as of December 31, 2025 and June 30, 2025, respectively. The effective interest rates for the revolving line of credit were 4.76% and 5.46% as of December 31, 2025 and June 30, 2025, respectively. There were no letters of credit issued under the multi-currency revolving credit facility as of December 31, 2025 and June 30, 2025.

*Mississippi Revenue Bond*

On August 1, 2007, the Company entered into an agreement with the State of Mississippi to provide financing for the acquisition and installation of certain equipment to be utilized at the Company's Southaven, Mississippi warehouse, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032. The bond accrues interest at the one-month term SOFR plus an adjustment of 0.10% plus a spread of 0.85%. The agreement also provides the bondholder with a put option, exercisable only within 180 days of each fifth anniversary of the agreement, requiring the Company to pay back the bonds at 100% of the principal amount outstanding. At December 31, 2025, the Company was in compliance with all covenants under this bond. The interest rates at December 31, 2025 and June 30, 2025 were 4.82% and 5.28%, respectively.

*Debt Issuance Costs*

At December 31, 2025, net debt issuance costs associated with the credit facilities, term loan and bond totaled $1.8 million and are being amortized on a straight-line basis through the maturity date of each respective debt instrument.

**(8) Derivatives and Hedging Activities**

The Company's results of operations could be materially impacted by significant changes in foreign currency exchange rates and interest rates. In an effort to manage the exposure to these risks, the Company periodically enters into various derivative instruments. The Company's accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with U.S. GAAP. The Company records all derivatives on the Condensed Consolidated Balance Sheet at fair value. Derivatives that are not designated as hedging instruments or the ineffective portions of cash flow hedges are adjusted to fair value through earnings in other income and expense.

*Foreign Currency Derivatives* – The Company conducts a portion of its business internationally in a variety of foreign currencies and is exposed to market risk for changes in foreign currency exchange rates. The Company attempts to hedge transaction exposures with natural offsets to the fullest extent possible and once these opportunities have been exhausted the

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

Company uses currency options and forward contracts or other hedging instruments with third parties. These contracts will periodically hedge the exchange of various currencies, including the U.S. dollar, Brazilian real, euro, British pound and Canadian dollar.

The Company had contracts outstanding for purposes of managing cash flows with notional amounts of $32.2 million and $26.2 million for the exchange of foreign currencies at December 31, 2025 and June 30, 2025, respectively. To date, the Company has chosen not to designate these derivatives as hedging instruments, and accordingly, these instruments are adjusted to fair value through earnings in other income and expense. Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures included in the Condensed Consolidated Income Statements for the quarters and six months ended December 31, 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Net foreign exchange derivative contract (gains) losses | $**(215)** | $(2418) | $**439** | $(1477) |
| Net foreign currency transactional and re-measurement losses | **873** | 2166 | **567** | 1560 |
| &nbsp;&nbsp;Net foreign currency exchange losses (gains) | $**658** | $(252) | $**1006** | $83 |

---

Net foreign currency exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses and are included in other income and expense. Foreign exchange gains and losses are primarily generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real and the Canadian dollar versus the U.S. dollar.

*Interest Rates -* The Company's earnings are affected by changes in interest rates due to the impact such changes have on interest expense associated with its floating-rate debt. To manage this exposure, the Company entered into separate interest rate swap agreements with a swap counterparty. These swaps include a notional amount of $50.0 million maturing on April 30, 2026, and a notional amount of $25.0 million maturing on March 31, 2028. The agreements are intended to mitigate interest risk by effectively converting a portion of the Company's borrowings from floating-rate to fixed-rate.

These interest rate swap agreements are designated as cash flow hedges to hedge the variable rate interest payments on the revolving credit facility. Interest rate differentials paid or received under the swap agreements are recognized as adjustments to interest expense. To the extent the swaps are effective in offsetting the variability of the hedged cash flows, changes in the fair value of the swaps are not included in current earnings, but are reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings for the quarters ended December 31, 2025 and 2024.

The components of the cash flow hedge included in the Condensed Consolidated Statement of Comprehensive Income for the quarters and six months ended December 31, 2025 and 2024, are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Net interest income recognized as a result of interest rate swap | $**(260)** | $(391) | $**(581)** | $(900) |
| Unrealized gain (loss) in fair value of interest rate swap | **46** | 745 | **60** | (139) |
| Net (decrease) increase in accumulated other comprehensive income | **(214)** | 354 | **(521)** | (1039) |
| Income tax effect | **(53)** | 87 | **(131)** | (256) |
| Net (decrease) increase in accumulated other comprehensive income, net of tax | $**(161)** | $267 | $**(390)** | $(783) |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The Company used the following derivative instruments at December 31, 2025 and June 30, 2025, reflected in its Condensed Consolidated Balance Sheets, for the risk management purposes detailed above:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **December 31, 2025** | **December 31, 2025** | **June 30, 2025** | **June 30, 2025** |
| |<br>**Balance Sheet Location** | **Fair Value of<br>Derivatives<br>Designated <br>as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Not Designated as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Designated <br>as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Not Designated as Hedge Instruments** |
| | | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Derivative assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts | Prepaid expenses and other current assets | $**—** | $**—** | $— | $15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreement | Other non-current assets | $**158** | $**—** | $680 | $— |
| Derivative liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency hedge | Accrued expenses and other current liabilities | $**206** | $**—** | $290 | $— |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

 **(9) Fair Value of Financial Instruments**

Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company classifies certain assets and liabilities based on the fair value hierarchy, which aggregates fair value measured assets and liabilities based upon the following levels of inputs:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include deferred compensation plan investments, forward foreign currency exchange contracts, foreign currency hedge agreements, interest rate swap agreements and contingent consideration owed to the sellers of Advantix Solutions Group, Inc ("Advantix"), Secure Path Networks, LLC dba Resourcive ("Resourcive") and DataXoom Corp. ("DataXoom"). The carrying value of debt is considered to approximate fair value, as the Company's debt instruments are indexed to a variable rate using the market approach (Level 2).

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis at December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total** | **Quoted<br>prices in<br>active<br>markets<br>(Level 1)** | **Significant<br>other<br>observable<br>inputs<br>(Level 2)** | **Significant<br>unobservable<br>inputs<br>(Level 3)** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | | | |
| Deferred compensation plan investments, current and non-current | $**35843** | $**35843** | $**—** | $**—** |
| Interest rate swap agreement | **158** | **—** | **158** | **—** |
| &nbsp;&nbsp;Total assets at fair value | $**36001** | $**35843** | $**158** | $**—** |
| **Liabilities:** |  |  |  |  |
| Deferred compensation plan investments, current and non-current | $**35843** | $**35843** | $**—** | $**—** |
| Foreign currency hedge | **206** | **—** | **206** | **—** |
| Liability for contingent consideration, current and non-current | **28600** | **—** | **—** | **28600** |
| &nbsp;&nbsp;Total liabilities at fair value | $**64649** | $**35843** | $**206** | $**28600** |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total** | **Quoted<br>prices in<br>active<br>markets<br>(Level 1)** | **Significant<br>other<br>observable<br>inputs<br>(Level 2)** | **Significant<br>unobservable<br>inputs<br>(Level 3)** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | | | |
| Deferred compensation plan investments, current and non-current | $31887 | $31887 | $— | $— |
| Forward foreign currency exchange contracts | 15 |  | 15 |  |
| Interest rate swap agreement | 680 |  | 680 |  |
| &nbsp;&nbsp;Total assets at fair value | $32582 | $31887 | $695 | $— |
| **Liabilities:** |  |  |  |  |
| Deferred compensation plan investments, current and non-current | $31887 | $31887 | $— | $— |
| Foreign currency hedge | 290 |  | 290 |  |
| Liability for contingent consideration, current and non-current | 19100 |  |  | 19100 |
| &nbsp;&nbsp;Total liabilities at fair value | $51277 | $31887 | $290 | $19100 |

---

The investments in the deferred compensation plan are held in a "rabbi trust" and include securities and cash equivalents for payment of non-qualified benefits for certain retired, terminated and active employees. These investments are recorded to prepaid expenses and other current assets or other non-current assets depending on their corresponding, anticipated distribution dates to recipients, which are reported in accrued expenses and other current liabilities or other long-term liabilities, respectively.

Derivative instruments, such as foreign currency forward contracts, are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers and interest rates quoted by banks (Level 2). Fair values of interest rate swaps are measured using standard valuation models with inputs that can be derived from observable market transactions, including SOFR spot and forward rates (Level 2). Foreign currency contracts and interest rate swap agreements are classified in the Condensed Consolidated Balance Sheets as prepaid expenses and other non-current assets or accrued expenses and other long-term liabilities, depending on the respective instruments' favorable or unfavorable positions. See Note 8 - *Derivatives and Hedging Activities*.

The Company recorded contingent consideration liabilities for Advantix, Resourcive, and DataXoom. These liabilities represent the amounts payable to sellers, as outlined under the terms of the individual purchase agreements, based upon the achievement of projected earnings before interest expense, taxes, depreciation and amortization, net of specific pro forma adjustments.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The following tables summarizes the fair value of the Company's contingent consideration liabilities at December 31, 2025 and December 31, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the six months ended** | **Contingent consideration for the six months ended** | **Contingent consideration for the six months ended** |
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Fair value at beginning of period | $**5430** | $**12609** | $**18039** | $**6660** | $**12440** | $**19100** |
| Issuance of contingent consideration | **9352** | **—** | **9352** | **9352** | **—** | **9352** |
| Payments |  | **—** | **—** | **(1375)** | **—** | **(1375)** |
| Change in fair value of contingent consideration | **1128** | **81** | **1209** | **1273** | **250** | **1523** |
| Fair value at end of period | $**15910** | $**12690** | $**28600** | $**15910** | $**12690** | $**28600** |
|  | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the six months ended** | **Contingent consideration for the six months ended** | **Contingent consideration for the six months ended** |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Fair value at beginning of period | $7500 | $9700 | $17200 | $— | $— | $— |
| Issuance of contingent consideration |  |  |  | 7500 | 9700 | 17200 |
| Change in fair value of contingent consideration | 473 | 670 | 1143 | 473 | 670 | 1143 |
| Fair value at end of period | $7973 | $10370 | $18343 | $7973 | $10370 | $18343 |

---

The fair values of amounts owed are recorded in current portion of contingent consideration and long-term portion of contingent consideration in the Company's Condensed Consolidated Balance Sheets. In accordance with ASC 805, the Company will revalue the contingent consideration liability at each reporting date through the last payment, with changes in the fair value of the contingent consideration reflected in the change in fair value of contingent consideration line item on the Company's Condensed Consolidated Income Statements that is included in the calculation of operating income. The fair value of the contingent consideration liability associated with future earnout payments is based on several factors, including but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• estimated future results, net of pro forma adjustments set forth in the purchase agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a risk premium reflective of the Company's creditworthiness and market risk premium associated with the United States markets.

*Specialty Technology Solutions*

The fair value of the contingent consideration related to Advantix is determined using a static discounted cash flow model. The liability recognized at December 31, 2025 was $6.4 million, of which $1.8 million is classified as current. The change in fair value for the quarter and six months ended December 31, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount and an increase in forecasts. The first earnout payment totaling $1.4 million was paid to the sellers of Advantix during the quarter ended September 30, 2025. Future earnout payments to the sellers of Advantix are payable based on results through fiscal year 2028.

The fair value of the contingent consideration related to DataXoom is determined using the Monte Carlo method. The liability recognized at December 31, 2025 was $9.4 million, of which $1.9 million is classified as current. The change in fair value for the quarter ended December 31, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount. Earnout payments to the sellers of DataXoom are payable based on results from fiscal years 2026 through 2028.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

*Intelisys & Advisory*

The fair value of the contingent consideration related to Resourcive is determined using the Monte Carlo method. The liability recognized at December 31, 2025 was $12.7 million, all of which is classified as current and is due to the sellers of Resourcive during fiscal year 2027. The change in fair value for the quarter and six months ended December 31, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount.

Significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities by segment related to acquisitions at December 31, 2025 and December 31, 2024 were as follows.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Significant observable inputs** | **Significant observable inputs** | **Significant observable inputs** | **Significant observable inputs** |
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** |
|<br>**Acquisition** | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Specialty Technology Solutions** | **Intelisys & Advisory** |
| Weighted-average payor credit spread | **1.75%** | **1.60%** | 1.80% | 1.80% |
| Weighted-average adjusted EBITDA risk premium | **12.10%** | **12.70%** | 15.75% | 13.70% |
| Adjusted EBITDA volatility | **60.00%** | **40.00%** |  | 40.00% |

---

**(10) Segment Information**

The Company is a leading provider of technology solutions and services to channel sales partners in specialty technology markets. The Company's Chief Executive Officer is our Chief Operating Decision Maker ("CODM") who evaluates how we allocate resources, assess performance and make strategic and operational decisions. The CODM reviews key financial measures for each reportable segment based on various financial results including net sales, gross profit and operating income. These measures are assessed in the annual budget process as well as on an actual-to-budget comparison and an actual-to-forecast comparison when making decisions about the allocation of resources to each segment. In addition to financial results such as net sales, gross profit, and operating income, the CODM also considers a range of operational and financial metrics, including EBITDA, return on invested capital, customer metrics and other strategic indicators. These tools support a comprehensive view of performance and inform strategic decisions across our reportable segments.

Corporate primarily includes corporate service costs that are not included in the CODM's assessment of the performance of each of the identified reportable segments. In connection with that assessment, our CODM may exclude matters, such as charges for impairments, significant, higher-cost restructuring programs, costs associated with separation activities, acquisition costs and other related charges, certain gains and losses from acquisitions or dispositions and certain litigation settlements. The CODM also reviews certain other measures including total assets and property and equipment by segment and geography.

Based on such evaluations, the Company has two reportable segments based on sales model.

*Specialty Technology Solutions Segment*

The Specialty Technology Solutions segment operates primarily in the United States and Brazil and includes specialty technology solutions distributed through a wholesale/resale sales model. This segment includes hardware, SaaS and subscription services. The specialty technology solutions include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Mobility and barcode - mobile computing, barcode scanners and imagers, RFID (radio frequency identification devices), barcode printing and related services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;POS - Point of Sale systems, integrated POS software platforms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Payment terminals - self-service kiosks including self-checkout, payment terminals and mobile payment devices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Physical security - video surveillance and analytics, video management software and access control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Networking - switching, routing and wireless products and software;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Communications - voice, video, communication platform integration and contact center solutions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Connectivity - managed connectivity and wireless enablement solutions.

*Intelisys & Advisory Segment*

The Intelisys & Advisory segment operates in the United States and consists of sales and services to both channel sales partners (Intelisys) and end users (Advisory). As a technology services distributor, or TSD, Intelisys distributes connectivity, cloud and

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

next-generation technologies through an agency sales model. Channel sales partners also have access to SaaS and subscription-based services through the company's proprietary tools, platforms and flexible routes to market. In addition to traditional telecom services, key technology areas include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Connectivity & SDN (Software-Defined Networking)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;CX (Unified Communications as a Service and Contact Center as a Service)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Cloud/Data Center

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Security

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Managed AI

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Wireless & IoT

By offering flexible routes to market and a robust solutions portfolio, this segment helps advisors service a wide range of end users including businesses of all sizes.

Selected financial information about the Company's segments for the quarters and six months ended December 31, 2025 and 2024 are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Corporate**<sup>(a)</sup> | **Total** |
| **Quarter ended December 31, 2025:** | | | | |
| Net Sales | $**741540** | $**24972** | $**—** | $**766512** |
| Cost of sales | **663312** | **290** | **—** | **663602** |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | **78228** | **24682** | **—** | **102910** |
| Other operating expenses<sup>(b)</sup> | **67227** | **17169** | **646** | **85042** |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $**11001** | $**7513** | $**(646)** | $**17868** |
| **Other Segment Items** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $**3703** | $**2235** | $**—** | $**5938** |
| Change in fair value of contingent consideration<sup>(d)</sup> | $**1128** | $**81** | $**—** | $**1209** |
| Capital expenditures | $**(1764)** | $**(211)** | $**—** | $**(1975)** |
| **Quarter ended December 31, 2024:** |  |  |  |  |
| Net Sales | $723277 | $24220 | $— | $747497 |
| Cost of sales | 645513 | 261 |  | 645774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 77764 | 23959 |  | 101723 |
| Other operating expenses<sup>(b)</sup> | 63687 | 17519 | 2073 | 83279 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $14077 | $6440 | $(2073) | $18444 |
| **Other Segment Items** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $5116 | $2296 | $719 | $8131 |
| Change in fair value of contingent consideration<sup>(d)</sup> | $473 | $670 | $— | $1143 |
| Capital expenditures | $(1865) | $(109) | $— | $(1974) |
| <sup>(a)</sup> For the quarter ended December 31, 2025, the amount in Other operating expenses unallocated to the segments include acquisition costs, cyberattack restoration costs. For the quarter ended December 31, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the quarter ended December 31, 2025, the amount in Other operating expenses unallocated to the segments include acquisition costs, cyberattack restoration costs. For the quarter ended December 31, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the quarter ended December 31, 2025, the amount in Other operating expenses unallocated to the segments include acquisition costs, cyberattack restoration costs. For the quarter ended December 31, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the quarter ended December 31, 2025, the amount in Other operating expenses unallocated to the segments include acquisition costs, cyberattack restoration costs. For the quarter ended December 31, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the quarter ended December 31, 2025, the amount in Other operating expenses unallocated to the segments include acquisition costs, cyberattack restoration costs. For the quarter ended December 31, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. |
| <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses |
| <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  |
| <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Corporate**<sup>(a)</sup> | **Total** |
| **Six months ended December 31, 2025:** | | | | |
| Net Sales | $**1456987** | $**49175** | $**—** | $**1506162** |
| Cost of sales | $**1294856** | $**923** | $**—** | $**1295779** |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | $**162131** | $**48252** | $**—** | $**210383** |
| Other operating expenses<sup>(b)</sup> | $**130755** | $**34921** | $**935** | $**166611** |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $**31376** | $**13331** | $**(935)** | $**43772** |
| **Other Segment Information** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $**7672** | $**4466** | $**—** | $**12138** |
| Change in fair value of contingent consideration<sup>(d)</sup> | $**1273** | $**250** | $**—** | $**1523** |
| Capital expenditures | $**(3938)** | $**(432)** | $**—** | $**(4370)** |
| **Six months ended December 31, 2024:** |  |  |  |  |
| Net Sales | $1475576 | $47501 | $— | $1523077 |
| Cost of sales | $1319355 | $380 | $— | $1319735 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | $156221 | $47121 | $— | $203342 |
| Other operating expenses<sup>(b)</sup> | $125405 | $34268 | $7595 | $167268 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $30816 | $12853 | $(7595) | $36074 |
| **Other Segment Information** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $9742 | $4423 | $1438 | $15603 |
| Change in fair value of contingent consideration<sup>(d)</sup> | $473 | $670 | $— | $1143 |
| Capital expenditures | $(4093) | $(255) | $— | $(4348) |
| <sup>(a)</sup> For the six months ended December 31, 2025, the amounts in Other operating expenses shown above include acquisition costs and cyberattack restoration costs. For the six months ended December 31, 2024, the amounts in Other operating expenses above include acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the six months ended December 31, 2025, the amounts in Other operating expenses shown above include acquisition costs and cyberattack restoration costs. For the six months ended December 31, 2024, the amounts in Other operating expenses above include acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the six months ended December 31, 2025, the amounts in Other operating expenses shown above include acquisition costs and cyberattack restoration costs. For the six months ended December 31, 2024, the amounts in Other operating expenses above include acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the six months ended December 31, 2025, the amounts in Other operating expenses shown above include acquisition costs and cyberattack restoration costs. For the six months ended December 31, 2024, the amounts in Other operating expenses above include acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. | <sup>(a)</sup> For the six months ended December 31, 2025, the amounts in Other operating expenses shown above include acquisition costs and cyberattack restoration costs. For the six months ended December 31, 2024, the amounts in Other operating expenses above include acquisition costs, cyberattack restoration costs, restructuring costs, and a legal settlement. |
| <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses. | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses. | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses. | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses. | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses. |
| <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses.  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses.  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses.  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses.  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses.  |
| <sup>(d)</sup> Change in fair value of contingent consideration is included within Other operating expenses. | <sup>(d)</sup> Change in fair value of contingent consideration is included within Other operating expenses. | <sup>(d)</sup> Change in fair value of contingent consideration is included within Other operating expenses. | <sup>(d)</sup> Change in fair value of contingent consideration is included within Other operating expenses. | <sup>(d)</sup> Change in fair value of contingent consideration is included within Other operating expenses. |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Quarter ended** | **Quarter ended** | **Six months ended** | **Six months ended** | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Sales by Geography Category:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;United States | **$** | **708802** | $| 689882 | **$** | **1391896** | $| 1405871 |
| &nbsp;&nbsp;Brazil | **59146** | **59146** | 60386 | 60386 | **116580** | **116580** | 123947 | 123947 |
| &nbsp;&nbsp;Less intercompany sales | **(1436)** | **(1436)** | (2771) | (2771) | **(2314)** | **(2314)** | (6741) | (6741) |
| Net sales <sup>(a)</sup> | **$** | **766512** | $| 747497 | **$** | **1506162** | $| 1523077 |
| <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended December 31, 2025 and 2024. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | |
| &nbsp;&nbsp;Specialty Technology Solutions | $**1522388** | $1564119 |
| &nbsp;&nbsp;Intelisys & Advisory | **219283** | 221487 |
|  | $**1741671** | $1785606 |
| **Property and equipment, net by Geography Category:** |  |  |
| &nbsp;&nbsp;United States | $**14351** | $15047 |
| &nbsp;&nbsp;Brazil | **17807** | 16122 |
|  | $**32158** | $31169 |

---

**(11) Leases** 

In accordance with Accounting Standards Codification ("ASC") 842, at contract inception the Company determines if a contract contains a lease by assessing whether the contract contains an identified asset and whether the Company has the ability to control the asset. The Company also determines if the lease meets the classification criteria for an operating lease versus a finance lease under ASC 842. Substantially all of the Company's leases are operating leases for real estate, warehouse and office equipment ranging in duration from 1 year to 10 years. The Company has elected not to record short-term operating leases with an initial term of 12 months or less on the Condensed Consolidated Balance Sheets. Operating leases are recorded as other non-current assets, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company has finance leases for information technology equipment expiring through fiscal year 2028. Finance leases are recorded as property and equipment, net, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The gross amount of the balances recorded related to finance leases is immaterial to the condensed consolidated financial statements at December 31, 2025 and the consolidated financial statements at June 30, 2025.

Operating lease right-of-use assets and lease liabilities are recognized at the commencement date based on the net present value of future minimum lease payments over the lease term. The Company generally is not able to determine the rate implicit in its leases and has elected to apply an incremental borrowing rate as the discount rate for the present value determination, which is based on the Company's cost of borrowings for the relevant terms of each lease and geographical economic factors. Certain operating lease agreements contain options to extend or terminate the lease. The lease term used is adjusted for these options when the Company is reasonably certain it will exercise the option. Operating lease expense is recognized on a straight-line basis over the lease term. Variable lease payments not based on a rate or index, such as costs for common area maintenance, are expensed as incurred. Further, the Company has elected the practical expedient under ASC 842 to recognize all lease and non-lease components as a single lease component, where applicable.

The following table presents amounts recorded on the Condensed Consolidated Balance Sheets related to operating leases at December 31, 2025 and June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | | **December 31, 2025** | **June 30, 2025** |
| **Operating leases** | **Balance Sheet location** | ***(in thousands)*** | ***(in thousands)*** |
| Operating lease right-of-use assets | Other non-current assets | $**10512** | $10258 |
| Current operating lease liabilities | Accrued expenses and other current liabilities | $**4502** | $3985 |
| Long-term operating lease liabilities | Other long-term liabilities | $**6715** | $6972 |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The following table presents amounts recorded in operating lease expense as part of selling general and administrative expenses on the Condensed Consolidated Income Statements during the quarters ended December 31, 2025 and 2024. Operating lease costs contain immaterial amounts of short-term lease costs for leases with an initial term of 12 months or less.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | **Six months ended December 31,** | **Six months ended December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Operating lease cost | $**1237** | $1094 | $**2467** | $2215 |
| Variable lease cost | **428** | 343 | **788** | 674 |
|  | $**1665** | $1437 | $**3255** | $2889 |

---

Supplemental cash flow information related to the Company's operating leases for the six months ended December 31, 2025 and 2024 are presented in the table below:

---

| | | |
|:---|:---|:---|
| | **Six months ended December 31,** | **Six months ended December 31,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Cash paid for amounts in the measurement of lease liabilities | $**2466** | $2285 |
| Right-of-use assets obtained in exchange for lease obligations | **1232** | 499 |

---

The weighted-average remaining lease term and discount rate at December 31, 2025 are presented in the table below:

---

| | |
|:---|:---|
| | **December 31, 2025** |
| Weighted-average remaining lease term | 2.87 years |
| Weighted-average discount rate | 6.39% |

---

The following table presents the maturities of the Company's operating lease liabilities at December 31, 2025:

---

| | |
|:---|:---|
| | **Operating leases** |
| | ***(in thousands)*** |
| 2026 | $2550 |
| 2027 | 4895 |
| 2028 | 2372 |
| 2029 | 1553 |
| 2030 | 986 |
| Total future payments | 12356 |
| Less: amounts representing interest | 1139 |
| Present value of lease payments | $11217 |

---

**(12) Commitments and Contingencies**

The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company's financial condition, results of operations or cash flows.

During the Company's due diligence for the Network1 acquisition, several pre-acquisition contingencies were identified regarding various Brazilian federal and state tax exposures. The Company recorded indemnification receivables that are reported gross of the pre-acquisition contingency liabilities as the funds were escrowed as part of the acquisition. There were no deposits into the escrow account; however, $0.4 million was released from the escrow account during the quarter ended December 31, 2025. During the fiscal year ended June 30, 2025, there were no deposits into the escrow account; however, $0.2 million was released from the escrow account. The amount available after the impact of foreign currency translation, as of December 31, 2025 and June 30, 2025, for future pre-acquisition contingency settlements or to be released to the sellers was $3.2 million and $3.4 million, respectively.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

The Company has recorded pre-acquisition contingencies and corresponding indemnification receivables related to Network1 of $3.6 million and $3.7 million at December 31, 2025 and June 30, 2025, respectively. These balances are presented as other non-current liabilities and other non-current assets in the Consolidated Balance Sheets. The amount of reasonably possible undiscounted pre-acquisition contingencies as of December 31, 2025 is estimated to range from $3.6 million to $14.8 million at this time, of which all exposures are indemnifiable under the share purchase agreement.

**(13) Income Taxes**

Income taxes for the quarters ended December 31, 2025 and 2024 have been included in the accompanying condensed consolidated financial statements using an estimated annual effective tax rate. In addition to applying the estimated annual effective tax rate to pre-tax income, the Company includes certain items treated as discrete events to arrive at an estimated overall tax provision. During the quarter ended December 31, 2025, a discrete net tax benefit of $2.4 million was recorded, which is attributable to a prior period provision to return adjustment in Brazil. During the quarter ended December 31, 2024, a discrete net tax benefit of $3.0 million was recorded, which is attributable to a reduction in the Company's prior year transition tax liability, a notional interest deduction on the net equity of the Company's Brazilian subsidiary, and stock compensation.

The Company's effective tax rate of 15.1% for the quarter ended December 31, 2025 differs from the current federal statutory rate of 21% primarily as a result of discrete items recognized during the quarter. The Company's effective tax rate of 21.6% for the six months ended December 31, 2025 differs from the current federal statutory rate primarily as a result income derived from tax jurisdictions with varying income tax rates, nondeductible expenses, and state income taxes. The Company's effective tax rate was 13.5% and 20.3% for the quarter and six months ended December 31, 2024.

As of December 31, 2025, the Company is not permanently reinvested with respect to all earnings generated by foreign operations. The Company has determined that there is no material deferred tax liability for federal, state and withholding tax related to undistributed earnings. During the quarter ended December 31, 2025, foreign subsidiaries repatriated cash of $13.4 million to the United States. There is no certainty to the timing of any future distributions of such earnings to the U.S. in whole or in part.

The Company had approximately $0.7 million of total gross unrecognized tax benefits at December 31, 2025 and June 30, 2025, respectively. At December 31, 2025, approximately $0.6 million of this total represents the amount of unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. The Company does not believe that the total amount of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.

The Company's policy is to recognize interest and penalties related to income tax matters in income tax expense. At December 31, 2025 and June 30, 2025, the Company had approximately $1.0 million accrued for interest and penalties.

The Company conducts business internationally and one or more of its subsidiaries files income tax returns in the U.S. federal, various state, local and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities in countries and states in which it operates. With certain exceptions, the Company is no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for the years before June 30, 2020.

**(14) Business Acquisitions**

On August 8, 2024, ScanSource acquired substantially all of the assets of Resourcive, a leading technology advisor, through its subsidiary ScanSource Agency, Inc. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses. On August 15, 2024, ScanSource acquired, through its subsidiary Advantix ScanSource, LLC, substantially all of the assets of Advantix, a managed connectivity experience provider specializing in wireless enablement solutions. The combined initial purchase price of these acquisitions, net of cash acquired, was approximately $56.7 million. The Advantix acquisition is included in the Specialty Technology Solutions segment, and the Resourcive acquisition is included in the Intelisys & Advisory segment. The purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values on the transaction dates.

On October 20, 2025, ScanSource completed the acquisition of DataXoom, a connectivity provider dedicated to supporting purpose-built mobile deployments across our current supplier line card and beyond. The initial cash purchase price totaled $18.4 million, in addition, the initial contingent consideration is valued at $13.4 million. DataXoom complements our Advantix investment and is included in the Specialty Technology Solutions segment. The allocation of the purchase prices to the assets and liabilities acquired, including the final valuation of the identifiable intangible assets and associated tax adjustments, have not been concluded as of the reporting date.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

All acquisitions include future earnout payments, and the Company recorded contingent consideration liabilities at the acquisition dates representing the fair value of estimated amounts payable to sellers. See Note 9 - *Fair Value of Financial Instruments* for the related disclosures regarding the contingent consideration liabilities recognized in connection with these acquisitions.

Intangible assets acquired include trade names, customer relationships, and developed technology. See Note 6 - *Goodwill and Other Identifiable Intangible Assets* for the amounts of goodwill and intangible assets recognized in connection with these acquisitions. Goodwill acquired through the Resourcive and Advantix acquisitions is deductible for tax purposes based on the asset purchase agreements executed. Goodwill acquired through the DataXoom acquisition is non-deductible for tax purposes based on the stock purchase agreement executed. The impact of these acquisitions was not material to the consolidated financial statements.

The Company continues to evaluate acquisitions on an on-going basis and has recognized $0.5 million and $0.8 million in acquisition-related costs for the quarter and six months ended December 31, 2025, respectively, and $0.2 million and $0.6 million for the quarter and six months ended December 31, 2024, respectively. Acquisition-related costs are included in selling, general and administrative expenses on the Condensed Consolidated Income Statements.

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

**Overview**

ScanSource is a leading technology distributor uniquely positioned to address complex, converging technologies and to accelerate growth for channel sales partners across hardware, SaaS, connectivity and cloud. We provide technology solutions and services from approximately 500 leading suppliers of mobility and barcode, POS, payment terminals, physical security, networking, communications, connectivity and cloud services to our approximately 25,000 channel sales partners located primarily in the United States and Brazil.

We operate our business under a management structure that enhances our technology distribution growth strategy. Our segments operate primarily in the United States and Brazil:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Specialty Technology Solutions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Intelisys & Advisory

We sell hardware, SaaS, connectivity and cloud solutions and services to channel sales partners that are designed to solve end users' challenges. We operate distribution facilities that primarily support our United States business in Mississippi, California and Kentucky. Brazil distribution facilities are located in the Brazilian states of Paraná, Espirito Santo and Santa Catarina. We provide some of our digital products, which include SaaS and subscriptions, through our digital tools and platforms.

**Recent Developments**

*Impact of the Macroeconomic Environment, Including Growth Outlook, Inflation and Tariffs*

The macroeconomic environment, including the economic impacts of growth outlook, inflationary pressures, tariffs and evolving geopolitical and trade relationships, continues to create significant uncertainty and may adversely affect our financial condition and results of operations. In 2025, the U.S. announced a variety of additional tariffs on goods from multiple nations and trading blocks, prompting reciprocal tariffs and other retaliatory actions in response. International trade policy and diplomatic dynamics continue to shift, and the full implications remain uncertain. We remain mindful of the potential impact these conditions could have on our channel sales partners, suppliers and end-user demand. We are actively monitoring changes to the global macroeconomic environment and assessing the potential impacts these challenges may have on our financial condition, results of operations and liquidity. We expect to pass through to our channel sales partners any supplier price increases resulting from tariffs. We are also mitigating related risks through strategic planning and maintaining financial flexibility, however we cannot predict the effectiveness of our mitigation strategies or the ultimate impact of tariffs and the global macroeconomic environment on our financial condition or results of operations.

On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was signed into law. The Act permanently extends key provisions of the Tax Cuts and Jobs Act, including 100% bonus depreciation, and introduces changes to the international tax framework. We are currently assessing the impact of the Act on our future effective tax rate, tax liabilities, and cash taxes.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

On October 20, 2025, we completed the acquisition of DataXoom, a leading connectivity provider dedicated to supporting purpose-built mobile deployments across our current supplier line card and beyond.

**Our Strategy**

Our strategy is to drive sustainable, profitable growth by providing complex, converging technology solutions through a growing ecosystem of channel sales partners leveraging our people, processes and tools. Our goal is to provide exceptional experiences for our channel sales partners, suppliers and employees, and we strive for operational excellence. Our differentiated technology distribution strategy utilizes multiple sales models to offer hardware, SaaS, connectivity and cloud services from leading technology suppliers to channel sales partners that solve end users' challenges. ScanSource enables channel sales partners to deliver solutions for their end users to address changing buying and consumption patterns. Our solutions may include a combination of offerings from multiple suppliers or give our channel sales partners access to additional services. As a trusted adviser to our channel sales partners, we provide converged solutions through our strong understanding of end-user needs.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**Results of Operations**

***Net Sales***

We have two reportable segments, which are based on sales channels. The following tables summarize our net sales results by operating segment and by geographic location for the quarters and six months ended December 31, 2025 and 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
| ***Net Sales by Segment:*** | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| Specialty Technology Solutions | $**741540** | $723277 | $18263 | 2.5% | 1.6% |
| Intelisys & Advisory | **24972** | 24220 | 752 | 3.1% | 3.1% |
| &nbsp;&nbsp;&nbsp;Total net sales | $**766512** | $747497 | $19015 | 2.5% | 1.7% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| Specialty Technology Solutions | $**1456987** | $1475576 | $(18589) | (1.3)% | (2.0)% |
| Intelisys & Advisory | **49175** | 47501 | 1674 | 3.5% | 1.9% |
| &nbsp;&nbsp;&nbsp;Total net sales | $**1506162** | $1523077 | $(16915) | (1.1)% | (1.9)% |

---

<sup>(a)</sup> A reconciliation of non-GAAP net sales in constant currency, excluding acquisitions, is presented at the end of *Results of Operations*, under *Non-GAAP Financial Information.*

***<u>Specialty Technology Solutions</u>***

The Specialty Technology Solutions segment consists of sales to channel partners primarily in the United States and Brazil. For the quarter ended December 31, 2025, net sales increased $18.3 million, or 2.5%, compared to the prior-year period. Excluding the impact of acquisitions and the impact of foreign exchange rate fluctuations, adjusted net sales increased $11.8 million, or 1.6%, for the quarter ended December 31, 2025. The increase for the quarter is primarily a result of growth in North America. For the six months ended December 31, 2025, net sales decreased $18.6 million, or 1.3%, compared to the prior-year period. Excluding the impact from acquisitions and the impact from foreign exchange rate fluctuations, adjusted net sales decreased $29.8 million, or 2.0%, for the six months ended December 31, 2025, compared to the prior-year period. The decrease in net sales for the six months is primarily due to lower large deals.

***<u>Intelisys & Advisory</u>***

The Intelisys & Advisory segment consists of sales and services to both channel partners (Intelisys) and end users (Advisory) in the United States. For the quarter and six months ended December 31, 2025, net sales increased $0.8 million, or 3.1%, and $1.7 million, or 3.5%, respectively, compared to the prior-year periods. The increase in net sales reflects Intelisys organic net sales growth. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $0.8 million, or 3.1%, and $0.9 million, or 1.9%, for the quarter and six months ended December 31, 2025, respectively. The increase in net sales for the quarter and six months ended December 31, 2025 reflects Intelisys organic net sales growth. Quarterly net billings for Intelisys increased 2.5% over the prior-year quarter to bring annualized net billings to approximately $2.85 billion.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
| ***Net Sales by Geography:*** | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| United States | $**707366** | $687111 | $20255 | 2.9% | 2.7% |
| Brazil | **59146** | 60386 | (1240) | (2.1)% | (9.4)% |
| &nbsp;&nbsp;Total net sales <sup>(b)</sup> | $**766512** | $747497 | $19015 | 2.5% | 1.7% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| United States and Canada | $**1389582** | $1399130 | $(9548) | (0.7)% | (1.1)% |
| Brazil | **116580** | 123947 | (7367) | (5.9)% | (10.4)% |
| &nbsp;&nbsp;Total net sales <sup>(b)</sup> | $**1506162** | $1523077 | $(16915) | (1.1)% | (1.9)% |

---

<sup>(a)</sup> A reconciliation of non-GAAP net sales in constant currency is presented at the end of *Results of Operations* in the non-GAAP section.

<sup>(b)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters and six months ended December 31, 2025 and 2024.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

***Gross Profit***

The following table summarizes our gross profit for the quarters and six months ended December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**78228** | $77764 | $464 | 0.6% | **10.5%** | 10.8% |
| Intelisys & Advisory | **24682** | 23959 | 723 | 3.0% | **98.8%** | 98.9% |
| &nbsp;&nbsp;&nbsp;Gross profit | $**102910** | $101723 | $1187 | 1.2% | **13.4%** | 13.6% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**162131** | $156221 | $5910 | 3.8% | **11.1%** | 10.6% |
| Intelisys & Advisory | **48252** | 47121 | 1131 | 2.4% | **98.1%** | 99.2% |
| &nbsp;&nbsp;&nbsp;Gross profit | $**210383** | $203342 | $7041 | 3.5% | **14.0%** | 13.4% |

---

Our gross profit is primarily affected by sales volume and gross margin mix. Gross margin mix is impacted by multiple factors, which include sales mix (proportion of sales of higher margin products or services relative to total sales), supplier program recognition (consisting of volume rebates, inventory price changes and purchase discounts) and freight costs. Increases in supplier program recognition decrease cost of goods sold, thereby increasing gross profit. Gross profit margin in our Intelisys & Advisory segment reflects a higher contribution of recurring revenue which is recorded on a net basis.

***<u>Specialty Technology Solutions</u>***

For the quarter ended December 31, 2025, gross profit dollars for the Specialty Technology Solutions segment increased $0.5 million, or 0.6%, compared to the prior-year quarter. Higher sales volumes, after considering cost of goods sold, and favorable supplier recognition program, impacted gross profit by $2.6 million. Higher freight costs reduced gross profit by $2.1 million for the quarter. Gross profit margin decreased 20 basis points over the prior-year quarter to 10.5%.

For the six months ended December 31, 2025, gross profit dollars increased $5.9 million, or 3.8%, compared to the prior-year period. Favorable sales mix and supplier program recognition positively impacted gross profit by $10.6 million. Higher freight costs and lower sales volume, after considering cost of goods sold, reduced gross profit by $4.7 million for the six months. Gross profit margin increased 54 basis points over the prior-year quarter to 11.1%.

***<u>Intelisys & Advisory</u>***

For the quarter ended December 31, 2025, gross profit dollars for the Intelisys & Advisory segment increased $0.7 million, or 3.0%, compared to the prior-year quarter. Higher sales volume primarily attributable to Intelisys increased gross profit for the quarter. Gross profit margin decreased 8 basis points compared to the prior-year quarter to 98.8%.

For the six months ended December 31, 2025, gross profit dollars increased $1.1 million, or 2.4%, compared to the prior-year period. Higher sales volume primarily attributable to Intelisys sales growth increased gross profit for the six months by $1.6 million. The increase in gross profit was partially offset by less favorable sales mix of $0.5 million due to a higher mix of services. Gross profit margin decreased 108 basis points over the prior-year quarter to 98.1%.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

***Operating Expenses***

The following table summarizes our operating expenses for the quarters and six months ended December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Selling, general and administrative expenses | $**78114** | $73920 | $4194 | 5.7% | **10.2%** | 9.9% |
| Depreciation expense | **1434** | 2902 | (1468) | (50.6)% | **0.2%** | 0.4% |
| Intangible amortization expense | **4285** | 5001 | (716) | (14.3)% | **0.6%** | 0.7% |
| Restructuring and other charges | **—** | 313 | (313) | (100.0)% | **0.0%** | 0.0% |
| Change in fair value of contingent consideration | **1209** | 1143 | 66 | *\*nm* | **0.2%** | 0.2% |
| &nbsp;&nbsp;Operating expenses | $**85042** | $83279 | $1763 | 2.1% | **11.1%** | 11.1% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Selling, general and administrative expenses | $**153388** | $145626 | $7762 | 5.3% | **10.2%** | 9.6% |
| Depreciation expense | **3011** | 5759 | (2748) | (47.7)% | **0.2%** | 0.4% |
| Intangible amortization expense | **8689** | 9359 | (670) | (7.2)% | **0.6%** | 0.6% |
| Restructuring and other charges | **—** | 5381 | (5381) | (100.0)% | **0.0%** | 0.4% |
| Change in fair value of contingent consideration | **1523** | 1143 | 380 | *\*nm* | **0.1%** | 0.1% |
| &nbsp;&nbsp;Operating expenses | $**166611** | $167268 | $(657) | (0.4)% | **11.1%** | 11.0% |

---

*\*nm - percentages are not meaningful*

Selling, general and administrative expenses ("SG&A") increased by $4.2 million, or 5.7%, and $7.8 million, or 5.3%, for the quarter and six months ended December 31, 2025, respectively, compared to the prior-year periods. The increase for the quarter and six-month period ended December 31, 2025 is primarily attributable to increased costs for employee-related expenses and costs related to acquisitions. SG&A includes customer specific bad debt expenses in Brazil for the quarter and six months ended December 31, 2025.

The decrease in depreciation expense of $1.5 million and $2.7 million during the quarter and six months ended December 31, 2025, respectively, is largely due to certain ERP software assets being fully depreciated in the previous fiscal year.

Restructuring and other charges of $0.3 million and $5.4 million were incurred in the quarter and six months ended December 31, 2024. Restructuring and other charges relate to employee separation and benefit costs in connection with our expense reduction and restructuring plans implemented during the prior fiscal year.

We present changes in fair value of the contingent consideration owed to the former shareholders of businesses that we acquire as a separate line item in operating expenses. We recorded a fair value adjustment expense of $1.2 million and $1.5 million in the quarter and six months ended December 31, 2025, respectively. The expense from changes in fair value of contingent consideration for the quarter and six months ended December 31, 2025 is largely due to the recurring amortization of the unrecognized fair value discount as well as the addition of a new acquisition in the quarter.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

***Operating Income***

The following table summarizes our operating income for the quarters and six months ended December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**11001** | $14077 | $(3076) | (21.9)% | **1.5%** | 1.9% |
| Intelisys & Advisory | **7513** | 6440 | 1073 | 16.7% | **30.1%** | 26.6% |
| Corporate | **(646)** | (2073) | 1427 | *\*nm* | ***\*nm*** | *\*nm* |
| &nbsp;&nbsp;Operating income | $**17868** | $18444 | $(576) | (3.1)% | **2.3%** | 2.5% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**31376** | $30816 | $560 | 1.8% | **2.2%** | 2.1% |
| Intelisys & Advisory | **13331** | 12853 | 478 | 3.7% | **27.1%** | 27.1% |
| Corporate | **(935)** | (7595) | 6660 | *\*nm* | ***\*nm*** | *\*nm* |
| &nbsp;&nbsp;Operating income | $**43772** | $36074 | $7698 | 21.3% | **2.9%** | 2.4% |

---

*\*nm - percentages are not meaningful*

***<u>Specialty Technology Solutions</u>***

For the Specialty Technology Solutions segment, operating income decreased $3.1 million, or 21.9% for the quarter ended December 31, 2025, compared to an increase of $0.6 million, or 1.8% for the six months ended December 31, 2025, compared to the prior-year periods. Operating margin was 1.5% and 2.2% for the quarter and six months ended December 31, 2025, respectively. The decrease in operating income for the quarter ended December 31, 2025 is primarily due to increased costs related to acquisitions as well as employee-related expenses. The increase in operating income for the six months is primarily due to higher gross profits for the six months ended December 31, 2025.

***<u>Intelisys & Advisory</u>***

For the Intelisys & Advisory segment, operating income increased $1.1 million, or 16.7%, and $0.5 million, or 3.7%, respectively, for the quarter and six months ended December 31, 2025, respectively, compared to the prior-year periods. Operating margin increased to 30.1% for the quarter ended December 31, 2025 and remained consistent at 27.1% for the six months ended December 31, 2025. The increase in operating income for the quarter comparative period is primarily driven by higher by sales volume.

***<u>Corporate</u>***

For the quarter and six months ended December 31, 2025, Corporate operating losses of $0.6 million and $0.9 million, respectively, primarily represents acquisition-related costs. For the quarter and six months ended December 31, 2024, Corporate operating losses of $2.1 million and $7.6 million, respectively, represent restructuring, acquisition-related costs and a legal settlement incurred in December 2024.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

***Total Other (Income) Expense***

The following table summarizes our total other (income) expense for the quarters and six months ended December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Interest expense | $**1946** | $1970 | $(24) | (1.2)% | **0.3%** | 0.3% |
| Interest income | **(3363)** | (2693) | (670) | 24.9% | **(0.4)%** | (0.4)% |
| Net foreign exchange losses (gains) | **658** | (252) | 910 | (361.1)% | **0.1%** | (0.0)% |
| Other, net | **(794)** | (291) | (503) | 172.9% | **(0.1)%** | (0.0)% |
| &nbsp;&nbsp;Total other (income) expense, net | $**(1553)** | $(1266) | $(287) | 22.7% | **(0.2)%** | (0.2)% |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Interest expense | $**3859** | $4078 | $(219) | (5.4)% | **0.3%** | 0.3% |
| Interest income | **(6543)** | (5352) | (1191) | 22.3% | **(0.4)%** | (0.4)% |
| Net foreign exchange losses | **1006** | 83 | 923 | 1112.0% | **0.1%** | 0.0% |
| Other, net | **(969)** | (5408) | 4439 | *nm\** | **(0.1)%** | (0.4)% |
| &nbsp;&nbsp;Total other (income) expense, net | $**(2647)** | $(6599) | $3952 | (59.9)% | **(0.2)%** | (0.4)% |

---

*\*nm - percentages are not meaningful*

Interest expense consists primarily of interest incurred on borrowings, non-utilization fees charged on the revolving credit facility and amortization of debt issuance costs. Interest expense decreased for the quarter and six months ended December 31, 2025 compared to the prior-year periods, primarily from lower average borrowings on our multi-currency revolving credit facility and lower interest rates.

Interest income increased for the quarter and six months ended December 31, 2025 primarily from higher interest income in Brazil.

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign exchange forward contracts gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real, the Canadian dollar versus the U.S. dollar, the euro versus the U.S. dollar, and the British pound versus the U.S. dollar. We partially offset foreign currency exposure with the use of foreign exchange contracts to hedge against these exposures. The costs associated with foreign exchange forward contracts are included in the net foreign exchange losses.

Other net income increased for the quarter ended December 31, 2025, due to a $0.8 million insurance recovery in connection with the cybersecurity attack in fiscal year 2023. Other net income decreased for the six months ended December 31, 2025 due to a larger insurance recovery of $5.4 million related to the cybersecurity attack recognized in the prior year period.

***Provision for Income Taxes***

For the quarter and six months ended December 31, 2025, income tax expense was $2.9 million and $10.0 million reflecting an effective tax rate of 15.1% and 21.6%, respectively. In comparison, for the quarter and six months ended December 31, 2024, income tax expense was $2.7 million and $8.6 million reflecting an effective tax rate of 13.5% and 20.3%, respectively. We expect the effective tax rate, excluding discrete items, for fiscal year 2026 to be approximately 27.2% to 28.2%. See Note 13 - Income Taxes to the Notes to Consolidated Financial Statements for further discussion.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**Non-GAAP Financial Information**

*Evaluating Financial Condition and Operating Performance*

In addition to disclosing results that are determined in accordance with United States generally accepted accounting principles ("US GAAP" or "GAAP"), we also disclose certain non-GAAP financial measures. These measures include non-GAAP operating income; non-GAAP pre-tax income; non-GAAP net income; non-GAAP EPS; adjusted earnings before interest expense, income taxes, depreciation, and amortization ("adjusted EBITDA"); adjusted return on invested capital ("adjusted ROIC"); and constant currency. Constant currency is a measure that excludes the translation exchange impact from changes in foreign currency exchange rates between reporting periods. We use non-GAAP financial measures to better understand and evaluate performance, including comparisons from period to period.

These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that we report may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with US GAAP.

*Adjusted Return on Invested Capital*

Adjusted ROIC assists us in comparing our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance during the year.

Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, share-based compensation expense, and other non-GAAP adjustments. Since adjusted EBITDA excludes some non-cash costs of investing in our business and people, we believe that adjusted EBITDA shows the profitability from our business operations more clearly.

We calculate adjusted ROIC as adjusted EBITDA, divided by invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. The following table summarizes annualized adjusted ROIC for the quarters ended December 31, 2025 and 2024, respectively:

---

| | | |
|:---|:---|:---|
|  | **Quarter ended December 31,** | **Quarter ended December 31,** |
| | **2025** | **2024** |
| Adjusted return on invested capital ratio, annualized <sup>(a)</sup> | **11.9%** | 13.3% |

---

(a)The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 92 days in the current and in the prior-year quarter.

The components of this calculation and reconciliation to our financial statements are shown on the following schedule:

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | |
|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| ***Reconciliation of net income to adjusted EBITDA:*** |  |  |
| &nbsp;&nbsp;Net income (GAAP) | $**16493** | $17053 |
| &nbsp;&nbsp;Plus: Interest expense | **1946** | 1970 |
| &nbsp;&nbsp;Plus: Income taxes | **2928** | 2657 |
| &nbsp;&nbsp;Plus: Depreciation and amortization | **5938** | 8132 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA (non-GAAP) | **27305** | 29812 |
| &nbsp;&nbsp;Plus: Change in fair value of contingent consideration | **1209** | 1143 |
| &nbsp;&nbsp;Plus: Share-based compensation | **3660** | 3021 |
| &nbsp;&nbsp;Plus: Acquisition costs <sup>(a)</sup> | **593** | 151 |
| &nbsp;&nbsp;Plus: Cyberattack restoration costs | **53** | 30 |
| &nbsp;&nbsp;Plus: Restructuring costs | **—** | 313 |
| &nbsp;&nbsp;Plus: Legal settlement | **—** | 1579 |
| &nbsp;&nbsp;Plus: Tax recovery | **(789)** | (750) |
| &nbsp;&nbsp;Plus: Insurance recovery, net of payments | **(838)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA (numerator for adjusted ROIC) (non-GAAP) | $**31193** | $35299 |

---

(a) Acquisition costs are generally non-deductible for tax purposes.

---

| | | |
|:---|:---|:---|
| | **Quarter ended December 31,** | **Quarter ended December 31,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| ***Invested capital calculations:*** |  |  |
| &nbsp;&nbsp;Equity – beginning of the quarter | $**914032** | $920893 |
| &nbsp;&nbsp;Equity – end of the quarter | **910886** | 900662 |
| &nbsp;&nbsp;Plus: Change in fair value of contingent consideration, net of tax | **907** | 861 |
| &nbsp;&nbsp;Plus: Share-based compensation, net | **2741** | 2271 |
| &nbsp;&nbsp;Plus: Acquisition costs <sup>(a)</sup> | **593** | 151 |
| &nbsp;&nbsp;Plus: Cyberattack restoration costs, net | **39** | 23 |
| &nbsp;&nbsp;Plus: Restructuring, net | **—** | 236 |
| &nbsp;&nbsp;Plus: Legal settlement | **—** | 1189 |
| &nbsp;&nbsp;Plus: Insurance recovery, net of payments | **(629)** |  |
| &nbsp;&nbsp;Plus: Tax recovery, net | **(2991)** | (2560) |
| &nbsp;&nbsp;Average equity | **912789** | 911863 |
| &nbsp;&nbsp;Average funded debt <sup>(b)</sup> | **131470** | 142143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Invested capital (denominator for adjusted ROIC) (non-GAAP) <sup>(c)</sup> | $**1044259** | $1054006 |

---

(a) Acquisition costs are generally non-deductible for tax purposes.

(b)Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt.

(c)The annualized adjusted EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for a leap year. There were 92 days in the current quarter and the prior-year quarter.

*Net Sales in Constant Currency Excluding Acquisitions*

We make references to "constant currency," a non-GAAP performance measure that excludes the foreign exchange rate impact from fluctuations in the average foreign exchange rates between reporting periods. Constant currency is calculated by translating current period results from currencies other than the U.S. dollar into U.S. dollars using the comparable average foreign exchange rates from the prior-year period. We also exclude the impact of acquisitions prior to the first full year of operations from the acquisition date in order to show net sales results on an organic basis. This information is provided to analyze underlying trends without the translation impact of fluctuations in foreign currency rates and the impact of acquisitions.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

Below we show organic growth by providing a non-GAAP reconciliation of net sales in constant currency excluding acquisitions:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Net Sales by Segment:*** | | | | |
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | |
|  | **2025** | **2024** | **$ Change** | **% Change** |
| **Specialty Technology Solutions:** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| &nbsp;&nbsp;Net sales, reported | $**741540** | $723277 | $18263 | 2.5% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(4412)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(2034)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**735094** | $723277 | $11817 | 1.6% |
| **Intelisys & Advisory:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**24972** | $24220 | $752 | 3.1% |
| **Consolidated:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**766512** | $747497 | $19015 | 2.5% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(4412)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(2034)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**760066** | $747497 | $12569 | 1.7% |
| <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Net Sales by Segment:*** | | | | |
| | **Six months ended December 31,** | **Six months ended December 31,** | | |
|  | **2025** | **2024** | **$ Change** | **% Change** |
| **Specialty Technology Solutions** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| &nbsp;&nbsp;Net sales, reported | $**1456987** | $1475576 | $(18589) | (1.3)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(5497)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(9204)** | (3512) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**1442286** | $1472064 | $(29778) | (2.0)% |
| **Intelisys & Advisory** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**49175** | $47501 | $1674 | 3.5% |
| &nbsp;&nbsp;Less: Acquisitions | **(1336)** | (577) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**47839** | $46924 | $915 | 1.9% |
| **Consolidated:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**1506162** | $1523077 | $(16915) | (1.1)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(5497)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(10540)** | (4089) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**1490125** | $1518988 | $(28863) | (1.9)% |
| <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024.  | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024.  | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024.  | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024.  | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024.  |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Net Sales by Geography:*** | | | | |
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | |
|  | **2025** | **2024** | **$ Change** | **% Change** |
| **United States:** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| &nbsp;&nbsp;Net sales, reported <sup>(a)</sup> | $**707366** | $687111 | $20255 | 2.9% |
| &nbsp;&nbsp;Less: Acquisitions | **(2034)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**705332** | $687111 | $18221 | 2.7% |
| **Brazil:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported <sup>(b)</sup> | $**59146** | $60386 | $(1240) | (2.1)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(c)</sup> | **(4412)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | $**54734** | $60386 | $(5652) | (9.4)% |
| **Consolidated:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported  | $**766512** | $747497 | $19015 | 2.5% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(c)</sup> | **(4412)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(2034)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | $**760066** | $747497 | $12569 | 1.7% |
| <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended December 31, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended December 31, 2025 and 2024. |
| <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.1% of Brazil net sales for the quarters ended December 31, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.1% of Brazil net sales for the quarters ended December 31, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.1% of Brazil net sales for the quarters ended December 31, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.1% of Brazil net sales for the quarters ended December 31, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.1% of Brazil net sales for the quarters ended December 31, 2025 and 2024. |
| <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2024. |
|  | **Six months ended December 31,** | **Six months ended December 31,** |  |  |
|  | **2025** | **2024** | **$ Change** | **% Change** |
| **United States and Canada:** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| &nbsp;&nbsp;Net sales, as reported | $**1389582** | $1399130 | $(9548) | (0.7)% |
| &nbsp;&nbsp;Less: Acquisitions | **(10540)** | (4089) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | **1379042** | 1395041 | $(15999) | (1.1)% |
| **Brazil:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported <sup>(a)</sup> | $**116580** | $123947 | $(7367) | (5.9)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(b)</sup> | **(5497)** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | $**111083** | $123947 | $(12864) | (10.4)% |
| **Consolidated:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**1506162** | $1523077 | $(16915) | (1.1)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(b)</sup> | **(5497)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(10540)** | (4089) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | $**1490125** | $1518988 | $(28863) | (1.9)% |
| (a) Countries outside of Brazil represent less than $0.1 million, or 0.1% of sales, for the six months ended December 31, 2025 and $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024. | (a) Countries outside of Brazil represent less than $0.1 million, or 0.1% of sales, for the six months ended December 31, 2025 and $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024. | (a) Countries outside of Brazil represent less than $0.1 million, or 0.1% of sales, for the six months ended December 31, 2025 and $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024. | (a) Countries outside of Brazil represent less than $0.1 million, or 0.1% of sales, for the six months ended December 31, 2025 and $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024. | (a) Countries outside of Brazil represent less than $0.1 million, or 0.1% of sales, for the six months ended December 31, 2025 and $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024. |
| <sup>(b)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024. | <sup>(b)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024. | <sup>(b)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024. | <sup>(b)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024. | <sup>(b)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2025 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2024. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Operating Income by Segment:*** | | | | | | |
| | **Quarter ended December 31,** | **Quarter ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
| **Specialty Technology Solutions:** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |  |
| GAAP operating income | $**11001** | $14077 | $(3076) | (21.9)% | **1.5%** | 1.9% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **2097** | 2740 | (643) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **1128** | 473 | 655 |  |  |  |
| &nbsp;&nbsp;&nbsp;Tax recovery, net | **(789)** | (750) | (39) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**13437** | $16540 | $(3103) | (18.8)% | **1.8%** | 2.3% |
| **Intelisys & Advisory:** |  |  |  |  |  |  |
| GAAP operating income | $**7513** | $6440 | $1073 | 16.7% | **30.1%** | 26.6% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **2188** | 2261 | (73) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **81** | 670 | (589) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**9782** | $9371 | $411 | 4.4% | **39.2%** | 38.7% |
| **Corporate:** |  |  |  |  |  |  |
| GAAP operating loss | $**(646)** | $(2073) | $1427 | \*nm | **\*nm** | \*nm |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition costs | **593** | 151 | 442 |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 313 | (313) |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **53** | 30 | 23 |  |  |  |
| &nbsp;&nbsp;&nbsp;Legal settlement | **—** | 1579 | (1579) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**—** | $— | $— | \*nm | **\*nm** | \*nm |
| **Consolidated:** |  |  |  |  |  |  |
| GAAP operating income | $**17868** | $18444 | $(576) | (3.1)% | **2.3%** | 2.5% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **4285** | 5001 | (716) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **1209** | 1143 | 66 |  |  |  |
| &nbsp;&nbsp;Tax recovery <sup>(a)</sup> | **(789)** | (750) | (39) |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition costs | **593** | 151 | 442 |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 313 | (313) |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **53** | 30 | 23 |  |  |  |
| &nbsp;&nbsp;&nbsp;Legal settlement | **—** | 1579 | (1579) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**23219** | $25911 | $(2692) | (10.4)% | **3.0%** | 3.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. |
| &nbsp;&nbsp;&nbsp;&nbsp;*\*nm - percentages are not meaningful* |  |  |  |  |  |  |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Operating Income by Segment:*** | | | | | | |
| | **Six months ended December 31,** | **Six months ended December 31,** | | | **% of Net Sales December 31,** | **% of Net Sales December 31,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
| **Specialty Technology Solutions:** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |  |
| GAAP operating income | $**31376** | $30816 | $560 | 1.8% | **2.2%** | 2.1% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **4313** | 5016 | (703) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **1273** | 473 | 800 |  |  |  |
| &nbsp;&nbsp;Tax recovery <sup>(a)</sup> | **(789)** | (750) | (39) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**36173** | $35555 | $618 | 1.7% | **2.5%** | 2.4% |
| **Intelisys & Advisory:** |  |  |  |  |  |  |
| GAAP operating income | $**13331** | $12853 | $478 | 3.7% | **27.1%** | 27.1% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **4376** | 4343 | 33 |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **250** | 670 | (420) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**17957** | $17866 | $91 | 0.5% | **36.5%** | 37.6% |
| **Corporate:** |  |  |  |  |  |  |
| GAAP operating loss | $**(935)** | $(7595) | $6660 | \*nm | **\*nm** | \*nm |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **81** | 106 | (25) |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition costs | **854** | 529 | 325 |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 5381 | (5381) |  |  |  |
| &nbsp;&nbsp;&nbsp;Legal settlement | **—** | 1579 | (1579) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**—** | $**—** | $— | \*nm | **\*nm** | \*nm |
| **Consolidated:** |  |  |  |  |  |  |
| GAAP operating income | $**43772** | $36074 | $7698 | 21.3% | **2.9%** | 2.4% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **8689** | 9359 | (670) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **1523** | 1143 | 380 |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **81** | 106 | (25) |  |  |  |
| &nbsp;&nbsp;Tax recovery <sup>(a)</sup> | **(789)** | (750) | (39) |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition costs | **854** | 529 | 325 |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 5381 | (5381) |  |  |  |
| &nbsp;&nbsp;&nbsp;Legal settlement | **—** | 1579 | (1579) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**54130** | $53421 | $709 | 1.3% | **3.6%** | 3.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Recovery of prior period withholding taxes in Brazil. |
| &nbsp;&nbsp;&nbsp;&nbsp;*\*nm - percentages are not meaningful* |  |  |  |  |  |  |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

*Additional Non-GAAP Metrics* 

To evaluate current period performance on a more consistent basis with prior periods, we disclose non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share. Non-GAAP results exclude amortization of intangible assets related to divestitures, cyberattack restoration costs and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. These metrics are useful in assessing and understanding our operating performance, especially when comparing results with previous periods or forecasting performance for future periods. Below we provide a non-GAAP reconciliation of the aforementioned metrics adjusted for the costs and charges mentioned above:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** | **Quarter ended December 31, 2025** |
| | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition costs** <sup>(a)</sup> | **Restructuring costs** | **Tax <br>recovery** | **Cyberattack <br>restoration costs** | **Insurance Recovery** | **Non-GAAP <br>measure** |
| | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| SG&A expenses | $**78114** | $**—** | $**—** | $**(593)** | $**—** | $**789** | $**(53)** | $**—** | $**78257** |
| Operating income | **17868** | **4285** | **1209** | **593** | **—** | **(789)** | **53** | **—** | **23219** |
| Pre-tax income | **19421** | **4285** | **1209** | **593** | **—** | **(789)** | **53** | **(838)** | **23934** |
| Net income | **16493** | **3199** | **907** | **593** | **—** | **(2991)** | **39** | **(629)** | **17611** |
| Diluted EPS | $**0.75** | $**0.14** | $**0.04** | $**0.03** | $**—** | $**(0.14)** | $**—** | $**(0.03)** | $**0.80** |
|  | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** | **Quarter ended December 31, 2024** |
|  | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition costs** <sup>(a)</sup> | **Restructuring costs** | **Tax <br>recovery** | **Cyberattack <br>restoration costs** | **Legal settlement** | **Non-GAAP <br>measure** |
|  | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| SG&A expenses | $73920 | $— | $— | $(151) | $— | $750 | $(30) | $(1579) | $72910 |
| Operating income | 18444 | 5001 | 1143 | 151 | 313 | (750) | 30 | 1579 | 25911 |
| Pre-tax income | 19710 | 5001 | 1143 | 151 | 313 | (750) | 30 | 1579 | 27177 |
| Net income | 17053 | 3745 | 861 | 151 | 236 | (2560) | 23 | 1189 | 20698 |
| Diluted EPS | $0.70 | $0.15 | $0.04 | $0.01 | $0.01 | $(0.11) | $— | $0.05 | $0.85 |
| (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the quarters ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** | **Six months ended December 31, 2025** |
| | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition costs** <sup>(a)</sup> | **Restructuring costs** | **Tax <br>recovery** | **Cyberattack <br>restoration costs** | **Insurance recovery** | **Legal settlement** | **Non-GAAP <br>measure** |
| SG&A expenses | $**153388** | $**—** | $**—** | $**(854)** | $**—** | $**789** | $**(81)** | $**—** | $**—** | $**153242** |
| Operating income | **43772** | **8689** | **1523** | **854** | **—** | **(789)** | **81** | **—** | **—** | **54130** |
| Pre-tax income | **46419** | **8689** | **1523** | **854** | **—** | **(789)** | **81** | **(838)** | **—** | **55939** |
| Net income | **36372** | **6488** | **1144** | **854** | **—** | **(2991)** | **61** | **(629)** | **—** | **41299** |
| Diluted EPS | $**1.63** | $**0.29** | $**0.05** | $**0.04** | $**—** | $**(0.13)** | $**—** | $**(0.03)** | $**—** | $**1.86** |
|  | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** | **Six months ended December 31, 2024** |
|  | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition costs** <sup>(a)</sup> | **Restructuring costs** | **Tax <br>recovery** | **Cyberattack <br>restoration costs** | **Insurance recovery** | **Legal settlement** | **Non-GAAP <br>measure** |
| SG&A expenses | $145626 | $— | $— | $(529) | $— | $750 | $(106) | $— | $(1579) | $144162 |
| Operating income | 36074 | 9359 | 1143 | 529 | 5381 | (750) | 106 |  | 1579 | 53421 |
| Pre-tax income | 42673 | 9359 | 1143 | 529 | 5381 | (750) | 106 | (4868) | 1579 | 55152 |
| Net income | 34028 | 7010 | 861 | 529 | 4054 | (2560) | 80 | (3667) | 1189 | 41524 |
| Diluted EPS | $1.39 | $0.29 | $0.04 | $0.02 | $0.17 | $(0.10) | $— | $(0.15) | $0.05 | $1.70 |
| (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition costs for the six months ended December 31, 2025 and 2024 are generally nondeductible for tax purposes. |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**Liquidity and Capital Resources**

Our primary sources of liquidity are cash flows from operations and borrowings under our $400 million revolving credit facility. Our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors, cash generated from operations and revolving lines of credit. In general, as our sales volume increases, our net investment in working capital increases, which typically results in decreased cash flow from operating activities. Conversely, when sales volume decreases, our net investment in working capital typically decreases, which typically results in increased cash flow from operating activities.

Our cash and cash equivalents balance totaled $83.5 million at December 31, 2025, compared to $126.2 million at June 30, 2025, including $31.1 million and $46.3 million held outside of the United States at December 31, 2025 and June 30, 2025, respectively. Checks released but not yet cleared in the amount of $0.2 million and $0.1 million are included in accounts payable at December 31, 2025 and June 30, 2025, respectively.

We conduct business primarily in the United States and Brazil where we generate and use cash. We provide for United States income taxes from the earnings of our Canadian and Brazilian subsidiaries. See Note 13 - *Income Taxes* in the Notes to the Consolidated Financial Statements for further discussion.

Our net investment in working capital, defined as accounts receivable plus inventories less accounts payable, decreased $1.7 million to $519.0 million at December 31, 2025 from $520.7 million at June 30, 2025, primarily from a decrease in accounts receivable, partially offset by an increase in inventories and a decrease in accounts payable. Our net investment in working capital is affected by several factors such as fluctuations in sales volume, net income, timing of collections from channel sales partners, increases and decreases to inventory levels, and payments to vendors.

---

| | | |
|:---|:---|:---|
| | **Six months ended** | **Six months ended** |
| | **December 31,** | **December 31,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Cash provided by (used in): |  |  |
| &nbsp;&nbsp;Operating activities | $**54052** | $38642 |
| &nbsp;&nbsp;Investing activities | **(22728)** | (58452) |
| &nbsp;&nbsp;Financing activities | **(73268)** | (52361) |

---

Operating cash flows are subject to variability period over period as a result of the timing of payments related to accounts receivable, accounts payable, and other working capital items. Net cash provided by operating activities was $54.1 million and $38.6 million for the six months ended December 31, 2025 and December 31, 2024, respectively. Cash provided by operating activities for the six months ended December 31, 2025 is primarily attributable to net income and changes in working capital balances. Compared to December 31, 2024, accounts payable and accounts receivable increased 10.8% and 10.3%, respectively.

The number of days sales outstanding ("DSO") was 71 days at December 31, 2025, compared to 70 days at June 30, 2025 and 66 days at December 31, 2024. Inventory turned 5.3 times during the quarter ended December 31, 2025, compared to 5.9 times during the quarter ended June 30, 2025 and 5.2 times in the prior-year quarter ended December 31, 2024.

Cash used in investing activities for the six months ended December 31, 2025 was $22.7 million, compared to cash used in investing activities of $58.5 million in the prior-year period. Cash used in investing activities for the six months ended December 31, 2025 represents cash paid for acquisitions and capital expenditures. Cash used in investing activities for the six months ended December 31, 2024 represents cash paid for acquisitions and capital expenditures offset by cash received for disposal of business.

Management expects capital expenditures for fiscal year 2026 to range from $8.0 million to $12.0 million, primarily for IT and warehouse investments.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

For the six months ended December 31, 2025 and December 31, 2024, cash used in financing activities totaled $73.3 million and $52.4 million, respectively. Cash used in financing activities for the six months ended December 31, 2025 represents repayments on long-term debt and common stock repurchases. Cash used in financing activities for the six months ended December 31, 2024 is primarily attributable to common stock repurchases.

***Credit Facility***

On December 18, 2025, the Company entered into a credit agreement (the "New Credit Agreement") with PNC Bank, National Association, as administrative agent ("PNC"), and the other lenders party thereto (the "Lenders"), providing for (i) a five-year, $400 million multicurrency senior secured revolving credit facility and (ii) a five-year $100 million senior secured term loan facility (the "New Credit Facilities"). In addition, pursuant to an "accordion feature," the Company may increase its borrowings by up to the greater of $250 million or 150% of the Company's EBITDA calculated on a Pro Forma Basis (each as defined in the New Credit Agreement), subject to obtaining additional credit commitments from the Lenders participating in the increase. The New Credit Agreement allows for issuance of up to $50 million for letters of credit. Borrowings under the New Credit Agreement are secured by substantially all of the assets of the Company and its domestic subsidiaries. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. The Company incurred debt issuance costs of $1.4 million in connection with the New Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.

Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at the Company's option, (i) the Term Secured Overnight Financing Rate ("SOFR") or daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's ratio of (A) total consolidated debt less its unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the "leverage ratio"); or (ii) the base rate plus an additional margin ranging from 0% to 0.75%, depending upon the Company's leverage ratio. All swingline loans denominated in U.S. dollars bear interest based upon the daily simple SOFR, floating daily, plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's leverage ratio, or such other rate as the Company and the applicable swingline lender may agree. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the New Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon the Company's leverage ratio. A commitment fee is payable on the unused amount of commitments under the revolving credit facility. The commitment fee ranges from 0.15% to 0.30%, depending on the Company's leverage ratio.

In connection with entering into the New Credit Agreement, on December 18, 2025, the Company terminated and repaid all indebtedness and other obligations outstanding under its Third Amended and Restated Credit Agreement (the "Prior Credit Agreement") with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto, which provided for (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility.

During the quarter and six months ended December 31, 2025, all of the Company's borrowings under New Credit Agreement and Prior Credit Agreement were U.S. dollar loans. The spread in effect as of December 31, 2025 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at December 31, 2025 was 0.15%. The effective interest rates for the term loan were 4.72% and 5.43% as of December 31, 2025 and June 30, 2025, respectively. The New Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, the Company's leverage ratio must be less than or equal to 3.50 to 1.00. In addition, the Company's Interest Coverage Ratio (as such term is defined in the New Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. The Company was in compliance with all covenants under the New Credit Agreement at December 31, 2025.

The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, was $1.7 million and $0.3 million during the six month periods ended December 31, 2025 and 2024, respectively. There was $400.0 million and $350.0 million available for additional borrowings as of December 31, 2025 and June 30, 2025, respectively. The effective interest rates for the revolving line of credit were 4.76% and 5.46% as of December 31, 2025 and June 30, 2025, respectively. There were no letters of credit issued under the multi-currency revolving credit facility as of December 31, 2025 and June 30, 2025.

***Summary***

We believe that our existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under our credit agreements, will provide sufficient resources to meet our present and

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

future working capital and cash requirements for at least the next twelve months. We also believe that our longer-term working capital, planned expenditures and other general funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities.

**Accounting Standards Recently Issued**

See Note 1 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on our consolidated financial position and results of operations.

**Critical Accounting Policies and Estimates**

Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. See Management's Discussion and Analysis of Financial Condition and Results from Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 for a complete discussion.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | |
|:---|:---|
| **Item 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

For a description of our market risks, see Part II, Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. No material changes have occurred to our market risks since June 30, 2025.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | |
|:---|:---|
| **Item 4.** | **Controls and Procedures** |

---

An evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") of the effectiveness of our disclosure controls and procedures at December 31, 2025. Based on that evaluation, our management, including the CEO and CFO, concluded that our disclosure controls and procedures are effective at December 31, 2025. During the quarter ended December 31, 2025, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**PART II. OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Legal Proceedings** |

---

The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to us, we believe that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on our financial condition or results of operations. For a description of our material legal proceedings, see Note 12 - *Commitments and Contingencies* in the notes to the condensed consolidated financial statements, which is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

In addition to the risk factors discussed in our other reports and statements that we file with the SEC, you should carefully consider the factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended June 30, 2025, which could materially affect our business, financial condition and/or future operating results.

There have been no material changes to the risk factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

---

| | |
|:---|:---|
| **Item 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

*Share Repurchases*

In April 2025, our Board of Directors approved a $200.0 million share repurchase authorization. The authorization does not have any time limit.

The following table presents the share-repurchase activity for the quarter ended December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares purchased** <sup>(1)</sup> | **Average price paid per share** | **Total number of shares purchased as part of the publicly announced plan or program** | **Approximate dollar value of shares that may yet be purchased under the plan or program** |
| October 1 - 31, 2025 | 119864 | $42.40 | 119864 | $191382205 |
| November 1 - 30, 2025 | 153346 | $40.28 | 153346 | $185205748 |
| December 1 - 31, 2025 | 150989 | $40.73 | 150562 | $179073051 |
| Total | 424199 |  | 423772 | $179073051 |

---

<sup>(1)</sup> Shares withheld from employees' stock-based awards to satisfy required tax withholding obligations totaled 427 for the month of December 2025. There were no shares withheld during the months of October and November 2025.

*Dividends*

We have never declared or paid a cash dividend. Under the terms of our credit facility, the payment of cash dividends is restricted.

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | |
|:---|:---|
| **Item 5.** | **Other Information** |

---

During the three months ended December 31, 2025, none of our directors or our officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

---

| | |
|:---|:---|
| **Item 6.** | **Exhibits** |

---

---

| | |
|:---|:---|
| **<u>Exhibit<br>Number</u>** | **<u>Description</u>** |
| 10.1 | <u>[Credit Agreement, dated as of December 18, 2025, by and among ScanSource, Inc., certain of its subsidiaries party thereto, as subsidiary borrowers, the lenders party thereto, and PNC Bank, National Association, as administrative agent (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K on December 19, 2025, and incorporated by reference herein).](https://www.sec.gov/Archives/edgar/data/918965/000119312525327081/d58956dex101.htm)</u> |
| 31.1 (a) | <u>[Certification of the Chief Executive Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](scansourceex311q2fy26.htm)</u> |
| 31.2 (a) | <u>[Certification of the Chief Financial Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](scansourceex312q2fy26.htm)</u> |
| 32.1 (b) | <u>[Certification of the Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](scansourceex321q2fy26.htm)</u> |
| 32.2 (b) | <u>[Certification of the Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](scansourceex322q2fy26.htm)</u> |
| 101 (a) | The following materials from our Quarterly Report on Form 10-Q for the quarter ended December 31, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at December 31, 2025 and June 30, 2025; (ii) the Condensed Consolidated Income Statements for the quarters and six months ended December 31, 2025 and 2024; (iii) the Condensed Consolidated Statements of Comprehensive Income for the quarters and six months ended December 31, 2025 and 2024; (iv) the Condensed Consolidated Statements of Shareholder's Equity for the quarters and six months ended December 31, 2025 and 2024; (v) the Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2025 and 2024; and (vi) the Notes to the Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL |
| 104 (a) | Cover page Inline XBRL File (Included in Exhibit 101) |
| (a) | Filed herewith |
| (b) | Furnished herewith |

---

------

<u>[**Table of Contents**](#i33e5888db1e649d28b3e2a350904839f_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | ScanSource, Inc. |
| Date: | February 5, 2026 | /s/ MICHAEL L. BAUR |
| | | Michael L. Baur |
| | | Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Date: | February 5, 2026 | /s/ STEVE JONES |
| | | Steve Jones |
| | | Senior Executive Vice President and Chief Financial Officer (Principal Financial Officer) |

---

---

| | | |
|:---|:---|:---|
| Date: | February 5, 2026 | /s/ BRANDY FORD |
| | | Brandy Ford |
| | | Senior Vice President and Chief Accounting Officer (Principal Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1** 

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Michael L. Baur, certify that:

1. I have reviewed this quarterly report on Form 10-Q of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ MICHAEL L. BAUR |
| Michael L. Baur<br>Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

Date: February 5, 2026

## Exhibit 31.2

**Exhibit 31.2** 

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Steve Jones, certify that:

1. I have reviewed this quarterly report on Form 10-Q of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ STEVE JONES |
| Steve Jones<br>Senior Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

Date: February 5, 2026

## Exhibit 32.1

**Exhibit 32.1**

Certification of the Chief Executive Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of ScanSource, Inc. (the "Company") on Form 10-Q for the quarter ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1)The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | February 5, 2026 | /s/ MICHAEL L. BAUR |
| | | Michael L. Baur<br>Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2** 

Certification of the Chief Financial Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of ScanSource, Inc. (the "Company") on Form 10-Q for the quarter ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1)The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | February 5, 2026 | /s/ STEVE JONES |
| | | Steve Jones<br>Senior Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

<br>